









The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 











DESIGN OF NOVEL COPPER(II) BASED 
ANTI-INFLAMMATORY DRUGS FOR THE 
ELEVATION ASSOCIATED WITH 
RHEUMATOID ARTHRITIS 
A Dissertation submitted to the 
UNIVERSITY OF CAPE TOWN 
In fulfilment of the requirements for the degree of 
MASTER OF SCIENCE 
Department of Chemistry 




































» My supervisor, Professor Graham Ellis Jackson, for his patience and support 
throughout the course of this study. 
» Professor Gert Kruger and O.Onajole at the University of KwaZulu Natal for 
synthesising the ligand. 
» UCT Chemistry department technical stuff. 
» Fellow members of our research group, Grace, Gadzikano, Pumeza, Mamohale, 
Everast, for the encouragements. 
» Members and staff and fellow students in the Chemistry Department (UCT) 
» The University of Cape Town Equity Scholarship, 1i~ and Crossley Post Graduate 
Scholar, Mintek and National Research Foundation (NRF) for financially assistance. 
» My parents for their love and support. 
» My partner Thobela 
CONFERENCE PROCEEDINGS 
This research study has been presented at the following conferences 
» Development of copper based anti-inflammatory drugs (adamentane derivatives), 
Z. Mhlambiso and G.E Jackson. October 2008, Cape Organometallic Symposium, 
Cape Town, South Africa. 
» Copper(II) anti-inflammatory drugs: A potentiomentric and spectroscopic study, 
Z.Mhlambiso and G.E Jackson, November-December 2008, South African Chemical 












It has been shown that copper complexes are able to alleviate inflammation associated with 
Rheumatoid Arthritis (RA). Serum copper levels are elevated in RA and it has been 
postulated that endogenous copper might have a protective function in chronic inflammatory 
conditions. 
In designing Cu(I1) anti-inflammatory drugs, one needs to know the stability constants of the 
ligand together with Cu(I1) and the competitive metal ions, Zn(I1) and Ca(I1) in blood plasma. 
For this purpose glass electrode potentiometry, infrared (lR) spectroscopy, nuclear magnetic 
resonance (NMR) spectroscopy, UV Nisible spectroscopy as well as blood plasma modelling 
were used to explore the coordination chemistry of a newly designed ligand, PCUL (Bis-(3-
aminoethy-2-aminomethylpyridine )-oxahexacyclo-dodecane). 
PCUL protonation and formation constants with Cu(I1) and Zn(I1) were investigated by 
potentiometric analysis at 2SoC and 0.ISmol/dm3 Na + (CI) The potentiometric analysis 
showed that CU(I1) formed far more stable complexes at physiological pH with PCUL than 
the in vivo competitor Zn(I1). 
In this study the IR spectroscopic analysis was used to determine the Cu(I1)-PCUL 
complexation sequence. The IR spectra show that the central amines are coordinated to the 
metal ion first. The small frequency shift between pH 4.02 to 6.91 proves that the pyridyl 
nitrogen atoms are also coordinated to CU(I1). 
The sequence of protonation and the coordination site of Cu(I1) were determined using NMR 
spectroscopy. UV Nisible spectroscopy was used for determining the number of possible 
chemical models present in solution. 
The blood plasma simulation studies using speciation modelling calculations shows that 
PCUL is poor in mobilizing Cu(I1) in vivo. PCUL substantially mobilizes Zn(I1) and there is 
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N1-(2-aminoethyl)-N2 -(pyridine-2-ylmethly)ethane-1 ,2-diamine 
ethylenediamine 
EST A task for initial estimates of stability constants values 
Equilibrium Simulation for Titration Analysis 
Disease modifying antirheumatic drugs 
Non-steroidal Anti-inflammatory Drugs 
Rheumatoid Arthritis 
Equilibrium of Constituent Concentrations in Large Equilibrium Systems 
plasma mobilizing index 
low molecular weight 
electromotive force 
Hamiltonian R -factor 
Hamiltonian R-lim 
-Log of the activity of the hydrogen ion 












OBJE Task to minimise the objective function in terms of the emf 
OBJT Task for optimising parameters with respect to reactant concentrations 
ZBAR Task to calculate the complex formation function 
Z-bar Complex formation function 
QBAR Task to calculate the deprotonation function 
Q-bar Deprotonation function 
(Jpqr denotes standard deviation in 10gPpqr for species pqr 
TH total proton concentration (mol/dm3) 
TL total ligand concentration (mol/dm3) 
TM total metal concentration (mol/dm3) 
[L] free ligand concentration (mol/dm3) 
Kw dissociation constant of water 
Ecell electrode potential (volts) 
EO electrode response intercept (volts) 
R universal gas constant 
T absolute temperature (Kelvin) 
F Faraday constant 
[W] hydrogen ion activity 
s electrode response slope 
ai activity 
"(i activity coefficient 
Ci concentration of ith ionic species 
I ionic strength (mol/dm3) 
G Gibbs free energy or chemical potential (kJ morl) 
GO Standard Gibbs free energy (kJ mOrl) 










nT total number of experiments 
np number of parameters being optimized 
n-bar number of protons bound to ligand in the absence of complexation 
Rr Hamiltonian R-factor 
Rlim H Hamiltonian R-limit 
1 ODq ligand field splitting 
g gerade 
u ungerade 
A..nax wavelength of maximum absorption 
h Planck's constant 
c speed of light 
1° intensity of incident radiation 
1 intensity of transmitted radiation 
E molar extinction coefficient 
Vmax frequency of maximum absorption 
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Figure 1: Structural formulae of ligands discussed in this study 

































1.1 RHEUMATOID A RTIIRJTIS 
Rh~umatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation 
ofthe joints [1]. RA is characterized by massive synovial proliferation and subintimal 
infiltration of inflammatory cells. which along "ith angiogenesis leads to the 
tonnation ofa very aggressive tissue, the pannus shown in Figure 1.1 [2]. 
Rheumatoid 
arthritis 
Figure 1. 1: The pannus formal;')n in RA 
The RA pannus consists of a hypertrophic synovial m~mbran~ composed of 
hyperplastic synoviocytes and inflammatory cells that infiltrate the synovial 
membrane [3]. The loss of joint fllllction occurs when expansion of the pannus 
induces bone erosion and cartilage thinning. One of the earliest phenomena observed 
in RA is synovial neovascular formation ddivering nutrients and oxygen to this 
proliferating pannus [4J_ It has bc~n shown that. angiogenesis inhibits the growth of 
the pannus in animal arthritis models. Vascular endothelia growth factor (VEGF) 
plays an important rolc in the pathogenesis of RA. 
Immunohistochemical and in silU hybridization studies indicate that VEGF is strongly 
expressed in sUbsynovial macrophages, in fibroblasts surrounding mierovessels, in 
vascular smooth muscle cells and in synoviocytes [4]. In the early stages of RA. 
VEGF expression is active and it continues throughout the course of the disease [4]. 
The VFiGF level in synovial fluid and tisslNs correlates with the clinical severity of 











Bone destruction also occurs when VEGF mediates the recruitment, chemotaxis, 
proliferation and osteoclast precursor macrophages. Macrophages and macrophage-
like cells form the interface between the innate and adaptive immune systems and in 
addition to presenting antigens; they are responsible for amplifying inflammatory 
response and mediating tissue injury [3]. 
RA is also characterized by increased production of the inflammatory cytokines 
tumour necrosis factor alpha (TNF-a), Interleukin-la(lL), IL-l~, and fibroblast 
growth factor (FGF-l). TNF-a appears to be a key mediator in the disease process, 
and IL-l~ plays a permissive role by acting to shift the whole-body protein 
metabolism towards net catabolism, to elevate resting energy expenditure and to 
increase joint pain and stiffuess [5]. In an experimental mouse models, treatment with 
antibodies against TNF-a, IL-la, and IL-2~ attenuated RA. FGF-l (Fibroblast growth 
factor) is important for the growth of synoviocytes in the course of RA [5]. 
RA is referred to as a systemic illness, sometimes called rheumatoid disease since it 
can affect multiple organs of the body. This occurs because patients with 
autoimmune disease have antibodies in their blood that target their own body tissues, 
where they can be associated with inflammation. RA can last for years, meaning that 
it is a chronic illness, hence patients may experience long periods without any 
symptoms [1]. 
The diagnosis of RA is based upon clinical manifestations or findings [6]. The initial 
indication of this disease is usually polyarthritis affecting the small joints of the hands 
and feet in a systematic fashion. Cervical spine and large joints may also be involved 
but the thoracic and lumbar spines are usually spared. The presence of subcutaneous 
rheumatoid nodules in radiologic demonstration and detection of an antibody in the 
serum called rheumatoid factor may confirm the diagnosis of the disease [6]. 
The etiology of RA remmns unknown; hence, its pathophysiology is poorly 
understood. Recent results show that rheumatoid synovial cells have a transformed 
phenotype. Synovial membrane (SM) immunohistological examination shows it to 











CD4+ T -cells belonging to the memory phenotype, activated macrophages and 
synoviocytes or specialised synovial fibroblasts and lysosomal enzymes. 
The aetiology of early events of RA remain unknown, the search for a bacterial or 
viral agent initiating the disease has been unrewarding, despite the variety of 
molecular and cellular approaches used [3]. It is, therefore possible that there is no 
single cause but rather a combination of genetic and environmental factors that 
contribute to the initiation of RA [3]. One hypothesis suggested that RA is an 
antigen-driven, T-cell dependent disease and that the inflammatory events are 
initiated by CD4+ T -cells recognizing antigens in the synovial tissue. However, to 
date, no specific, common antigen has been identified in the synovium of different 
RA patients [3]. It is possible that a variety of antigens is involved in the T-cell 
response and that the antigen or epitopes presented to T -cells vary during the course 
of the disease [3]. T -cells also appear to play a pivotal role in the conversion of the 
synovium into lymphoid tissue [3]. Free oxygen radicals (e.g., superoxide and 
hydrogen peroxide) have been implicated as mediators of tissue damage in RA, along 
with proinflammatory cytokines, particularly efNF-a) [5]. In the synovial fluid of 
RA patients, free radical oxidation products have been identified and these products 
are thought to be generated by activated macrophages, monocytes, granulocytes, as 
well as by anoxic reperfusion reactions that may occur with the movement of affected 
joints [5]. 
In metabolism of aerobes, the superoxide radical anion Oi- is encountered via one-
electron reduction of molecular oxygen [7]. The superoxide radical is very toxic 
because it is an intermediate or occasional byproduct during respiration and as an 
immune response product of phagocytes during respiratory burst. Superoxide has 
been implicated in oxidative damage phenomena, along with hydrogen peroxide 
(H202) and hydroxyl radical (OH), related to aging, inflammation and postischemic 
injury via reperfusion. Nature utilizes superoxide dismutase (SODs), in order to 
provide cellular defence against the oxidative stress by catalyzing Oi-












So far. three unrelaTed kinds of SOD's have been characterized. all being 
metalloenzymes [5]. These clases have been classified depending on their active si te 
metal ion content mainly: eu-and Zn-dcpendcnt SODs [7]. Copper and zinc 
containing enzymes among SODs arc probably the most abundant found in all 
cukaryotcs and many prokaryotcs. 
RA is a common disease affecting 50/0 of the Western World, afflicts equally all races 
or people with women amkted more than men, in a ratio of2-3:1 [8] . In adults, the 
disease is prevalent in the age range 40-60 years although i( can occur in any age [9]. 
Multiple memocrs can be affected in SOI1lC families. hence suggesting genetic basis 
for the disorder. The symptoms and progression of this disease can be controlled 
using immunosuppressive and anti-inflammatory drugs; however, there is no cure for 
this disease and treatment or chronic RA remains largely symptomatic [1J. 
Schematic representation of a normal Osteoarthritis and Rheumatoid arthritic joints 
DI"C sho""TI in Figure 2.1. 
N u",,~' Ju',,' 
", ,,,,,, " '.' 
,,"~ 'u" ,, ' ,, ' 
Nonnal and Arthritic ..Joints 
f'igure 1.2: ero .. ""crioo ora i1eahhy and di seased joilll 
The synovial joint consists of si.x basic comlxmcnts. which arc; joint capsule, joint 
cavity, synovial membrane (synoviwn), synovial fluid, bones coming togcther to form 
joints and hyalinc cartilage [9J. 
The Jbility of 0. tlOI1J\3.J synovial joint to runction properly as a load bearing structure 
dcpcoos on thc intcgrity and correct alignment of the opposing surro.ccs or the 











synovial capsule is composed of two layers, an outer fibrous and an inner synovium 
[9]. The outer layer is not well vascularised and it consists mainly of joint receptors 
innervating it, while the synovium is well vascularised but poorly innervated [9]. The 
functional characteristics of the connective tissue in the joints are determined by their 
chemical composition [9]. These tissues are composed mainly of proteoglycans, 
collagen and glycoproteins [9]. 
The articular cartilage has the ability to decrease stress on the contact joint surfaces by 
minimizing friction and wear between two opposing joint surfaces during movement 
and to dissipate forces on the joint over a wide area. There are two substances, which 
are found in the synovial fluid, namely: hyaluronic acid and a glycoprotein called 
lubricin, both of these substances are responsible for lubrication of the joints. 
Hyaluronic acid lubricates the joint capsule and lubricin lubricates the cartilage. 
Nutrients are carried to and wastes are carried from the vascular components of the 
joint via the synovial fluid that serves as the transport medium [10]. 
The ends of the long bones that form the synovial joints are composed of a soft, 
spongy . bone called subchondral bone, which is covered and protected by hyaline 
cartilage [11]. Proliferation of synovial granulation tissue takes place at the cartilage 
in regions where the bone is not protected. The cartilage then becomes exposed to 
destructive enzymes from the synovial fluid and the pannus, which remove 
proteoglycans from the cartilage by redial cleavage [11]. 
The superficial layers of the cartilage, which are assumed to be deposited by the 
immune complex, act as chemoattractents from the synovial pannus, causing the 
granulomatous response to spread throughout the joints. Thus, the chronicity and 
persistence of rheumatoid inflammation occurs due to the presence of cartilage 
together with immune complex [11]. This therefore constitutes the mechanism of 
joint destruction leading to erosion of articular cartilage and subchondral bone (as 
shown by Figure 1.2) resulting in the permanent and debilitating structural damage 











1.2 Drug therapy for RA 
The acceptable treatment for RA should have the following features; highly 
efficacious, devoid of side effects, affordable and acceptable to the patient. 
Traditionally, copper rich diets such as crayfish and peanuts were administered as a 
way of treatment of RA [12]. Antioxidant micronutrients playa vital role as part of 
the mechanism that protects against tissue damage caused by reactive oxygen species 
[5]. Antioxidants also suppress the expression of cytokines and collagenase induced 
by tumor necrosis factor-a, which suggests additional mechanisms of protection 
against RA [5]. This suggests that antioxidant compounds may provide protection 
against the development or progression of RA. Diets high in fruits or vegetables have 
also been suggested to be protective against RA [6]. Copper jewellery was accepted 
as a standard treatment. However, scientific therapeutics have been slowly replacing 
this traditional approach. 
Such therapeutic drugs can conveniently be classified into three categories: 
1. Nonsteroidal anti-inflammatory drugs (NSAID)s 
2. Glucocorticosteroids and 
3. Disease-modifying antirheumatic drugs (DMARD)s. 
1.2.1 NSAIDs 
NSAIDs are characterized by an absence of steroid moiety in their structure as the 
name indicates [10]. They are referred to as first class drugs and are medications that 
can reduce tissue inflammation, joint pain, stiffness and swelling. The NSAIDs 
include salicylates, for instance aspirin and large number of non-salicylates, which are 
generally weak carboxylic or enolic derivatives [13]. These drugs are used in doses 
higher than the doses required for treating headaches and fever, aspirin acts as an 
effective anti-inflammatory medication for RA. Aspirin has been used for joint 
problems since the ancient Egyptian era [1]. 
The new NSAIDs require fewer doses per day, hence are just as effective as aspirin in 
reducing inflammation and pain. Beside their anti-inflammatory activities, NSAIDs 











inhibition of the cyclo-oxygenase pathway of prostaglandin (PO) synthesis. Since 
NSAIDs suppress PO synthesis, gastric acid production is increased whereas the 
production of gastric mucosa is also decreased, thus impairing the normal protective 
mechanism of the stomach [14]. Several other PO-independent mechanisms of action 
has been proposed such as inhibition of collagenase, stabilization of lysosomal 
membranes and disruption of membrane-associated enzymatic functions, which 
generate the superoxide radical [14]. 
While these drugs are generally well tolerated, they are also associated with a wide 
range of potential clinical toxicities. The most common side effects of asprin and 
other NSAIDs include gastrointestinal tract (OIT) irritation and stomach upset. The 
damage to the OIT mucosa by NSAIDs can occur via a number of mechanisms [15]. 
Such mechanisms include direct topical irritation to the OIT epithelium, impaired 
barrier properties of the mucosa, reduced gastric mucosal blood flow, interference 
with the repair of superficial injury and suppression of gastric prostaglandin synthesis 
[15]. 
1.2.2 Glucocorticosteroids 
These drugs are used in treatment of RA because of their anti-inflammatory and 
immunosuppressive effects [4]. They include compounds such as cortisone, 
prednisone and dexamethasone amongst others. They have numerous metabolic and 
physiological effects, affecting lymphocytes, granulocytes, macrophages, cell 
membranes as well as inhibiting the immune system. The mechanisms which result in 
such effects produced by glucocorticosteroids are rather complex. Steroids are 
believed to inhibit phospholipase A2, which release arachidonic acid from cell 
membranes [16]. Corticosteroids are not considered to have disease-remitting 
potential, although this has recently been questioned since protection against joint 
erosion has been reported [16]. 
Olucocorticosteroids are administered as oral and parenteral preparations [16]. The 
later are given inta-articularly or at peri-articular sites of local inflammation and are 
effective at relieving pain and swelling [16]. Hydroxylation of prednisone to 











drugs such as prednisolone or methylprednisolone are preferred in patients with faulty 
hydroxylation systems or else the patient will appear unresponsive to these 
medications. Suppression of the pituitary-adrenal axis for about one week can occur 
in patients taking 50 mg of prednisone daily after only 5 days [17]. 
Disadvantages of glucocorticosteroids include inhibition of collagen synthesis and 
stabilization of lysosomal membranes. Many serious side effects are associated with 
the use of corticosteroids, especially their effects on bone and the GI tract. Glucose 
intolerance, increased susceptibility to infections and impaired wound healing are 
other complications of glucocorticosteroids. It is difficult to discontinue their use as 
some patients may develop a steroid-dependence [18]. 
1.2.3 Disease-modifying antirheumatic drugs (DMARD)s. 
These drugs are aimed not only in treating the symptoms of RA but also at 
suppressing the disease at the source by diverting the course of the pathologic reaction 
[19]. DMARDs are referred to as 'second-line' or 'slow -acting' medicines. They 
are used for long period at varying doses and may take weeks or months for benefits 
of the drugs to be noted. DMARDs promote remission, thereby retarding the 
progression of the joint destruction and deformity if effective. Recent studies show 
that patients who respond to DMARDs with control of the rheumatoid disease may 
actually decrease the known risk of lymphoma that exists from simply having 
rheumatoid arthritis. However, the mechanism of action of DMARDs remains 
unknown. DMARDs include sulfasalazine (SSZ), D-penicillamine, various 
antimalarial and gold compounds, as well as the more recent immunoregulators 
cyclophosphamide, azathioprine (AZA) and methotrexate (MTX) [18]. 
Disadvantages of DMARDS include; clinical toxicity and patients need frequent 
evaluation by their physicians. Toxicity varies from 20% in sulfasalazine up to 60% 













D-penicillamine has been used as a therapy for RA for many years [4]. Previous 
studies suggested that D-penicillamine might reduce rheumatoid synovial hyperplasia 
via Fas-mediated apoptosis, but the mechanism of the effect ofD-penicillamine is still 
unknown [4]. Side effects of such drugs include fever, chills, mouth sores, metallic 
taste in the mouth, skin rash, kidneys and bone marrow damage, stomach upset and 
easy bruising [1]. Routine blood and urine tests are required to patients on such 
medication. This medication increases the level of histidine while hydroxychloroquine 
stabilizes the level [21]. D-penicillamine resembles one of the amino acid, cystein, 
hence it is thought to be very effective in altering the course of the disease. Its mode 
of action is thought to be via its ability to bind firmly to plasma proteins, including 
albumin, a-globulin and ceruloplasmin via the disulfide linkage [21]. 
(b). Antimalarials 
The antimalarials are among the least effective and the least toxic of the slow-acting 
agents and their efficacy is largely a matter of opinion. Among the currently available 
antimalarial drugs, only chloroquine (CQ) and hydroxychloroquine (HCQ) are widely 
used. The actions of these compounds are identical; the only difference between them 
is that HCQ has an -oH on the ethyl group attached to the terminal nitrogen that 
occurs only in HCQ. The absorption of both HCQ and CQ after oral administration is 
essentially complete [20]. The drugs are plasma bound «60%; albumin, aI-acid 
glycoprotein) but distributes widely and due to the extensive tissue biding and ion 
trapping, accumulates to impressive degree in the lung, kidney, spleen, melanin-
containing tissues and also leucocytes [20]. 
Binding reflects intercalation in DNA, binding to macromolecules, such as melanin, 
and binding to phospholipids. [20]. HCQ exists in both ionised and unionised forms 
at physiological pH, where the unionized forms can diffuse throughout membranes 
and the ionized one cannot. The free permeable, unionized species allow initial 
movement of the drug into the cells and subcellular structures. However, once the 
drug is inside subcellular structures where pH is low, it becomes completely ionized 











Since melanin has a high capacity for HCQ/CQ, very significant quantities of the drug 
accumulates during chronic administration. The retina has high melanin content; 
hence, accumulation of the drug to the retina is associated with occurrence of visual 
difficulties, including blindness. Vision also may be impaired by drug deposition in 
the cornea, although the relative frequency of such deposit is unclear [20]. 
(c). Sulfasalanine (SSZ) 
SSZ is a diazo conjugate of 5-aminosalicylic acid (which has some inflammatory 
activity) (5-ASA) and sulfapyridine [20]. After oral administration, the intact drug is 
poorly absorbed. Orally absorbed drug is reduced in the liver and its component 
liberated [20]. In the gut lumen, intact drug can be broken down to its components in 
the upper gastrointestinal tract, after which sulfapyridine is rapidly absorbed. These 
drugs are thought to modify lymphocyte function and inhibit rheumatoid factor (RF) 
synthesis as well as cyclo-oxygenase and proteolytic enzyme activity [20]. Basic 
cellular processes such as thiol-disulphide exchange, the collagenase enzyme reaction 
and nucleoprotein interaction are the effects of antimalarial drugs. They also inhibit 
anti-inflammatory properties, such as inhibition of prostaglandin (PG) synthesis and 
superoxide release by neutrophils, as well as stabilizing lysosomal membrane and 
suppressing phagocytosis [18]. Previous research indicated that gold affects 
complement activation and decreases serum concentrations of immunoglobulins 
through effect on macrophages and B-Iymphocytes [18]. 
The side effects of SSZ are common to most sulphonamides and include 
gastrointestinal effects, hypersensitivity reactions and blood dyscrasias [20]. 
Mechanisms are generally not known for most of the aforementioned side effects [7]. 
Macrocytic anaemia can occur during sulfasalazine therapy since the sulfapyridine 
acts to prevent microbial synthesis of folic acid and because humans are entirely 
dependent on folic acid produced by their gastrointestinal flora. The above effect can 











(d). Azathioprine (AZA) 
This drug is a prodrug that is metabolized to its active form 6-mercaptopurine (6MP) 
[20]. AZA is converted to (6MP) in vivo. Both AZA and 6MP have essentially 
identical properties and activities. AZA possess better oral absorption characteristics, 
which combined with its longer time action, accounts for its use in preference to 6MP 
[20]. AZA is a substituted analog of the naturally occurring purine, guanine [20]. 
Although effects on S-phase are primary, AZA can also affect RNA and protein 
synthesis in growth phases (0), 01 and 02, although higher doses may be required 
[20]. 01 is much more sensitive to drug effects; hence, since it precedes the S-phase, 
high drug level effects at 01 can actually prevent entry into the S-phase and thus limit 
the degree of cytotoxicity [20]. That is why AZA (6MP) is sometimes referred to as 
an S-phase specific, self-limited drugs [20]. This drug targets proliferating cells and 
has a differing degree to effect in proportion to the degree of proliferative activity 
[20]. 
AZA has anti-inflammatory and immunoregulatory activity, inhibiting monocyte 
production, B cell proliferation and y-globulin synthesis [20]. This effect has been 
observed upon its conversion to 6MP. After several month of administration, AZA 
has been noted to cause a peripheral lymphopenia to RA patients. The reduction 
includes both B- and T - lymphocytes, with greater reduction occurring in T -helper. 
AZA appears to modify the function of B-Iymphocytes, because T -suppressor 
function is very sensitive to AZA, more so than B-cells in general, B-antibody 
responses may actually be accentuated by low doses of AZA [20]. 
The unwanted side effects of AZA therapy include; bone marrow suppression, 
expressed as leukopenia of thrombocytopenia, or both [20]. The production of bone 
marrow suppression, hepatic damage and gastrointestinal effects probably occur via 
biochemical mechanisms [20]. An alkylating agent that inhibits DNA replication, 
cyclophosphamide acts by affecting B cell function that results in decreased 
immunoglobulin production [18]. AZA decrease serum immunoglobulins and 
suppress antibody response [18]. 6MP can produce severe hepatic toxicity, but this is 
usually in antineoplastic doses. However, lower doses of 6MP produce less toxicity. 











doses and the relatively slow release of 6MP from the prodrug [20]. The unwanted 
gastrointestinal toxicity as a side effect of AZA, is diminished in 6MP [20]. 
(d). Methotrexate (MTX) 
MTX is an analog of folic acid and its basic action is that of an antimetabolite [20]. 
This drug is a weak organic acid that is primarily in an ionized very water soluble 
form above pH 7, below pH 7 it is relatively insoluble [20]. Almost complete 
absorption occurs in doses used orally in the therapy of RA. Following absorption, 
this drug is widely distributed and actively taken up into the cells via the transporters 
for 5-methyltetrahydrofolate (5-methyl-FH.), for which 5-formyl-FH. (leucovorin) is 
also a ligand [20]. In the synovial fluid and the surrounding cells, significant levels of 
MTX are found. MTX can be polyglutamylated, once inside the cells, with one to 
four glutamyl residues possible and two common. 
The polyglutamated forms remain inside the cells since they are charged and too large 
for diffusion to occur. Differing rates and extents of polyglutamylation of MTX are 
demonstrated by different types of cells. Cells with low capacity accumulate less 
MTX and are less likely to develop toxic side effects, while those cells with high 
capacity and rate will accumulate significant quantities ofMTX and are more likely to 
develop toxicity. Since MTX also affects RNA and protein synthesis, it can be 
classified with AZAl6MP, i.e., MTX is an S-phase (proliferation)-specific self-limited 
antimetabolite [20]. Unlike AZA, MTX is not metabolised to any extent, although 
small amounts of 7-0H-MTX may be formed [20]. 7-0H-MTX is insoluble than 
MTX, however it is less toxic. MTX is renally eliminated by both filtration and 
active secretion via the tubular organic acid transporter. 
When MTX is used in therapy of RA at low doses, side effects related to bone 
marrow suppression (leukopenia, thrombocytopenia), damage to gastro-intestinal 
mucosa (nausea, anorexia, diarrhea and vomiting, mucositis, stomatitis) and skin 
rashes, (alopecia) which occur in any agent that inhibits cell replication are 
uncommon, in the order of 5%. MTX serious adverse reactions affect; the liver, 
lungs, GIT, renal production and central nervous systems. Hence, the use of MTX is 











1.3 Background to study 
1.3.1 The involvement of Copper in RA 
Long before the extensive biochemical studies of the affected tissue, copper was 
already associated with RA [4]. Copper occurs as the metal in oxidation states (0), 
(I), (II) and unstable (III) [4]. Copper occurs as Cu(II) ion in an aqueous solution, 
which mainly depends on pH, temperature, presence of bicarbonate and sulphide and 
the presence of potential complexing agents such as amino acids, certain peptides and 
detergents [4]. Copper is an essential trace element that acts as a cofactor for a 
variety of enzymes by virtue of its ability to accept and donate electrons under 
physiologic conditions [4]. Copper is an essential component of a number of 
important enzymes, including: 
1. The free radical scavenger- superoxide dismutase (SOD) - required for the 
destruction of superoxide radicals [22]. 
2. Tyrosine -for the synthesis of dihydroxyphenyl-alanine which is subsequently 
transformed to melanin, required for pigmentation [22]. 
3. Cytochrome c oxidase - involved in oxidative metabolism, brain functioning 
haem synthesis and phospholipid synthesis [22]. 
4. The neurotransmitter, dopa-p-mono-oxygenase-for conversion of dopamine to 
norepinephrine, which is a neural hormone important in the transmission of 
nerve impulses [22]. 
5. Lysyl oxidase - required for connective tissue in the lungs and bones [23]. 
Most of the copper in living organisms, including humans, plays the role of a cofactor 
for specific enzymes and electron transport proteins involved in energy or antioxidant 
metabolism [23]. Copper ions have recently demonstrated to be required for the 
assembly of multiprotein release complexes in the process of stress-induced 
nonclassical release of FGF-I and IL-In [4]. These two proteins lack a signal 
sequence in their primary structures and cannot be released through the classical 
endoplasmic reticulum-Golgi pathway [4]. Copper is also known to playa vital role 











Copper, in its metal form, is malleable, ductile and a good conductor of heat and 
electricity. It is a major constituent of most alloys and has been termed one of man's 
most important metals, the ore having been mined for over 5000 years [24]. Copper 
is in fact the third most abundant metallic element in the human body following iron, 
calcium, potassium, magnesium and sodium. The normal adult body contains 
between 75 and 50 mg of copper, the average person consuming about 3 mg daily 
[24]. 
Copper and its complexes can have a dual nature [25]. The copper amino acid 
complex of glycine has been found to be an irritant, a response that is observed in 
copper salts and metallic copper [25]. Copper does not exist in any significant 
amount in free ionic states, hence its beneficial effects supercedes the adverse side. 
1.3.2 Copper Biochemistry 
Copper enters mammals through the alimentary tract, it does not enter mammals 
through skin, unless, for instance, it is applied in high concentrations in the form of 
specific ointments or if copper bracelet is worn, where it was observed that through 
sweat bracelets were solubilised and promoted dermal absorption of copper into the 
blood stream [23]. In mammals, absorption of copper occurs exclusively in the small 
intestines after digestion of food in the stomach and duodenum [23]. On entering 
cells, copper normally finds its way readily to the different sites where it is needed 
[23]. Most of the incoming copper rapidly finds its way into the hepatocytes of the 
liver and the brain, with less amounts entering the heart, spleen, kidney and blood 
[23] The iris and choroid of the eye have very high copper levels [23]. The data from 
human studies indicated that, in the range of normal intakes, there is some adaptation 
of absorption relative to need; higher percentages of the available copper are absorbed 
at lower intakes and vice versa [23]. 
Absorption of copper across the brush border into the cells of the intestinal mucosa, 
and its subsequent transfer across the basolateral membrane into the interstitial fluid 
and blood occur by different mechanisms [23]. Transfer across the mucosal barrier 
probably occurs by non-energy-dependent diffusion [23]. Transfer of copper across 











energy-depended mechanism. Additional diffusion or carrier-mediated systems in the 
basolateral membrane come into play at higher intakes of copper and it seems these 
are the sites where competition for absorption between copper and other transition 
metal ions take place [23]. 
Most of the ingested copper is excreted via the bile, the major excretory route, thus 
preventing tissue toxicity [26]. Trace amounts of copper are excreted via urine except 
in cases of copper overload [26]. Excess copper in the tissue leads to the production 
of damaging free radicals and subsequent DNA cleavage [26]. Specific proteins are 
required in each step of copper transport pathway. These proteins are cell receptors, 
membrane transporters involved in metal influx and efflux and a series of intracellular 
transporters [26]. 
The design and synthesis of a peptide molecule mimicking the specific Cu(II)-
transport site of human serum albumin provided an ideal opportunity to study in detail 
the coordination equilibria existing in approximated physiological conditions [27]. 
Serum albumin is a major metal binding protein in the body, with about 40 J.1g of 
copper able to bind to the albumin in one of the most extensively studied binding site 
of any protein [12]. Cu(II) bound to albumin is exchangeable and is known to be the 
transport form of Cu(II) in the blood. [27]. The proposed structure of major Cu(II) 
binding site in HSA is shown in Figure 1.3. This structure involves the a-NH2 
nitrogen, two peptide nitrogens and the imidazole nitrogen of the N-terminal Asp-Ala-
His residue [29]. 
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Sarkar and Co-workers have suggested that the ternary complex L-histidine-Cu(II)-
albumin acts as an intermediate in the exchange of Cu(II) in blood between a 
macromolecule such as albumin and low molecular weight substances like amino 
acids [27]. Because Cu(II) bound to the designed peptide diglycyl-L-histidine 
simulates many characteristics of Cu(II)-albumin, the ternary system L-histidine-
Cu(II)-diglycyl-L-histidine can be considered as the representative of the ternary 
complex L-histidine-Cu(II)-albumin [30]. 
Initially, Cu(II)-transport site was suggested to involve the a-amino nitrogen, two 
intervening peptide nitro gens and the imidazole nitrogen of the histidine residue in 
position 3 [12]. Subsequent investigations were carried out by Laussac and Sarkar 
with simple tripeptide molecules, e.g., glycylglycyl-L-histidine and glycylglycyl-L-
histidine N-methyamide that were designed to mimic the proposed Cu(II)-transport 
site of human serum albumin (HSA). The results showed many similarities between 
HSA and these peptides in their Cu(II)-binding properties [12]. 
The Cu(II) cation is well known for its ability to interact with histidyl residues in 
peptides, especially with those containing the N-terminal sequence X-V-His that is 
encountered in serum albumin [29]. Tripeptides with histidine in the 3rd position 
were widely studied for the complexation of Cu(II) ion as mimicking fragment for the 
N-terminal sequence of serum albumin [29]. These peptides contain a carboxylate 
group on the histidyl residue that does not exist in the protein structure [29]. This 
draw back is avoided by substitution of the histidyl residue by histamine. Hence, the 
pseudopeptides X-Y-Ha (Ha: histamine) can be used to evaluate the complexing 
ability towards the Cu(II) ions, although other models are possible, namely those 
using histidine residue in the amide form [29]. Previously this was done with Gly-
Gly-Ha, which gave rise to the formation of the 4-N complex MLH..2, as with Gly-
Gly-His with slightly lower formation constant [31]. 
The carrageenen foot oedema model of RA has been used in clinical studies on mice, 
and it was found that irrespective of the complex administered, at a moderate dose of 
9.3mg/kg, approximately 60% reduction in inflammation was obtained [29]. 











treated with anti-inflammatory drugs, the use of metal chelating agents has grown 
[29]. There has been an upsurge of interest in the metal ion therapeutics, within the 
last decade for both diagnosis and treatment [29]. Cu(II)-L-histidine, for instance, has 
been used in the treatment of Menkes disease [2, 3,]. Such interest has been due to 
the biochemical and pharmacological properties of the metal-ligand system, with 
extensive research carried out to determine the role of the ligands in copper uptake 
into the cells [29]. The effective role of various copper chelating agents in the 
alleviation of inflammation associated with RA have appeared in many articles, 
indicating the physiological importance of these agents as well as their therapeutic 
applications [29]. 
1.3.3 Anti-inflammatory mechanisms of copper complexes 
Generally, copper is believed to possess anti-inflammatory activity since patients with 
RA exhibit changes in copper distribution in the blood. An increase in total serum 
copper is observed in arthritis suffers compared with the controls. This was observed 
as an increase in CP-bound copper and a decrease in albumin-bound and low 
molecular weight (l.m.w) copper resulting in low levels ofbio-available copper in the 
blood [18]. Altered copper concentrations have also been observed in the synovial 
fluid of RA patients and some researchers suggest that alterations in copper are a 
cause of the disease while others do believe that it is a physiological response to the 
disease and that copper plays an essential role in its control and treatment [32]. 
It has been suggested that copper complexes of clinically used antiarthritis drugs were 
formed in vivo and that they were responsible for the beneficial effects of these drugs 
[32]. In a comparison of the effectiveness of copper, gold and silver thiomalate and 
thiosulphate in models of inflammation, the copper complexes were effective; while 
the activity of the gold and silver complexes was much lower [29]. 
There are several possible mechanisms for the anti-inflammatory activity of copper 
complexes [12]. The copper may induce lysyl oxidase activity, modulate 
prostaglandin synthesis, induce or mimic superoxide dismutase activity, decrease the 












(a). Induction of Lysyl Oxidase 
The repair of damaged tissue requires cross-linking and extracellular mutation of the 
tissue components, collagen and elastin [33]. Lysyl oxidase that is copper dependent 
enzyme is responsible for this process [33]. It has been observed that lysyl oxidase 
activity is induced in copper deficient chickens with copper(II) sulphate [33]. 
(b). Modulation of Prostaglandin Synthesis 
Copper complexes have been shown to decrease the synthesis of pro-inflammatory 
(vasodilator) prostaglandin, PGE2 and a concomitant increase in the synthesis of the 
anti-inflammatory prostaglandin (vasoconstrictor), PGF2a [32]. Modulation of the 
biosynthesis by copper complexes is an attractive mechanism for the action of copper 
[32]. 
(c). Induction of Superoxide Dismutase and Dismutase-Mimic Activity 
Superoxide dismutase is known to have anti-inflammatory and arthritic activity [32]. 
The human superoxide dismutase contains copper at the site and is required for its 
dismutase activity [32]. This enzyme [32] disproportionate the superoxide anion that 
initiates inflammation. 
(d). Stabilization of Lysosomal Membranes 
Copper is reported to decrease the permeability of human synovial lysosomes, thus 
decreasing the release of free lysosomal enzymes [32]. Lysosomal enzymes are found 











( e). Modulation of the Activity of Histamine 
Modulation of the physiological effects of histamine may also be an important 
biochemical role for copper complexes. It is found that copper-histamine complexes 
are the active form of histamine [22]. 
Some reports reveal that the possibility of inhibiting both fibroti response and 
inflammatory response by copper chelation is due to the suppression of transforming 
growth factor beta and TNF-(l production [4]. 
1.3.4 Computer Based Approach 
Most of the serum copper is non-reversibly bound to ceruloplasmin, the fraction of 
copper, which will be concerned with a localised deficiency, is the labile component 
comprising the albumin and low molecular weight (l.m.w) bound copper and the free 
metal ion [34]. The l.m.w fraction is thought to be important in the transport of metal 
ions across cell membranes and between biological sites [34]. However, their role in 
biological systems is not easy to investigate as the concentration of these complexes is 
generally below the analytical means of detection [34]. 
A computer simulation of the equilibrium reactions between transition metal ions and 
low molecular weight ligands was considered the only reliable way to determine 
which of the thousands of possible complexes would be important under biological 
conditions [34]. A blood plasma model developed by May et al (May, Linder, and 
Williams, 1997) has been successfully used to account for several processes in drug 
therapy [34]. Computer simulation in this regard is the calculation of the equilibrium 
concentrations of the individual species formed in the solution of metal ions and 
ligands [34]. The model requires the thermodynamic formation constants for all the 
complexes present in the mixture and the overall concentrations of components [34]. 
The computer program called ECCLES (Evaluation of Constituent Concentrations) 
was developed to permit the simulation of large and comprehensive systems [35]. 
Concentration scans are done in simulation data to ensure that the imposed free 











weight ligands [35]. In the free metal concentration range that was scanned, the 
extent of complexation of low weight ligands is far greater than total concentration of 
metal ligand complexes [35]. This is because of the very low total concentration of 
the transition metal, the weak bonding abilities of calcium(II) and magnesium(II) and 
the decrease in metal ion concentration due to protein binding [35]. 
Computer modelling using ECCLES has provided evidence in support of the 
hypothesis that the administration of l.m. w copper complexes would be beneficial in 
the treatment ofRA [35]. The use of chelating drugs to displace the labile albumin in 
favour of the tissue is the most convenient way of utilizing endogenous copper 
reserves [35]. For this to occur it requires a drug, which is able to complete 
effectively with the protein for the metal ion and that the predominant metal complex 
formed in plasma should readily diffuse into the affected synovial tissue [35]. 
The extent to which administered therapeuticals may be able to fulfil these conditions 
can be judged by simulating their effects in plasma using ECCLES [35]. Plasma 
Mobilising Index (p.M.I) is a function used to ascertain whether the agent is 
sufficiently powerful and copper specific. Drugs that successfully bind copper ion in 
vivo in the presence of competing endogenous ligands produce large P .M.I values, 
which for copper are calculated as follows [35]. 
(P.M.I) = Total low molecular weight (I.m.w) concentration in plasma in presence of the drug 
Totall.m.w Cu(II) concentration in normal plasma 
Several investigations were carried out by researchers based upon the above 












1.3.5 Ligand design 
The design of a therapeutic generally requires knowledge of the difference between 
the health and disease state at a molecular level [36]. The most straightforward way 
of administering the copper is by injection, unfortunately, this is associated with 
several undesirable side effects [36]. Two general routes, as illustrated by scheme 
below [36] may achieve the increase in the local concentration of copper complexes. 
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Figure 1.4: Routes for increasing the concentration ofL.m.w copper complexes in 
Blood plasma [6]. 
Endogenous rather than exogenous sources seem appropriate for short term therapy 
[12]. 
There are three ways of achieving this aim: 
1. By equilibrium competition for the labile protein-bound copper. 
2. By decreasing the affinity of serum albumin for copper by allosteric effects. 











1.3.6 Ligand requirements 
It has been shown that copper complexes are able to alleviate the inflammation 
associated with RA [37]. In order to achieve successful metal ion administration and 
subsequent mobilization in the body fluids, several general requirements have to be 
fulfilled [37]. The most important requirements of a ligand which will complex 
copper and increase its bioavailability and at the same time not disrupt the 
homeostasis of other endogenous metal ions are listed below [6]; 
1. The ligand must be a strong chelator in order to form thermodynamically 
stable complexes with the metal ion at physiological conditions of temperature 
and pH, thus minimizing loss to competing serum proteins [38]. 
2. The complex should also be primarily a nitrogen donor ligand so that the 
selectivity for the soft Cu(II) is increased over the harder Zn(II) and Ca(II) 
[38]. 
3. The complex must be formally uncharged and hence lipophilic to enable 
transport across cell membranes and prevent urinary excretion [38]. 
4. If the complex is to be administered orally, an addition requirement of stability 
at the low pH's encountered in stomach fluid must also be satisfied [38]. 
5. For dermal absorption the complex cannot be too lipophilic otherwise it will 










1.3.7 Choice of ligands 
Potential ligands must possess several thermodynamically desirable characteristics, in 
order to be able to meet the above requirements for metal ion mobilization [35]. 
Enhanced stability is not the only criterion for successful mobilization, but selectivity 
as well as other physical attributes of the complex plays an important role [35]. 
Ligands that have predominantly nitrogenous donor groups confer a high degree of 
selectivity towards Cu(II) upon such chelating agents [35]. Other cations, such as 
Ca(II) and Zn(II) can drastically interfere with ligands designed to bind Cu(II) in vivo, 
particularly if predominantly oxygen donor groups are present [35]. 
The design of the copper-chelating agent for the alleviation of inflammation 
associated with RA was based upon two important assumptions [36]. The therapeutic 
activity depends upon increasing the total labile Cu(II) concentration in some body 
compartments other than plasma and only neutral complexes will pass through a 
membrane separating these compartments whereas charged complex generally do 
not, in absence of a specific uptake pathway [36]. Ligands can be used to either 
mobilize copper endogenous or exogenous reserves, thus increasing the low 
molecular weight (l.m.w) fraction of copper complexes in the body fluids [36]. The 
major copper storage protein ceruloplasmin, which accounts for more than 90% of 
serum Cu, binds Cu irreversibly and would thus need to be denatured for its copper to 
be accessible [36]. 
Essentially, endogenous copper is only available from serum albumin (SA) which is 
the main copper transport protein in blood. Due to the fact that ceruloplasmin 
concentration increases in response to the development of RA, hence its concentration 
in RA sufferer increases [36]. Exogenous copper administration seems to be the only 
realistic means of increasing the body pool of labile uncharged low molecular weight 
(l.m.w) Cu(II) complexes [36]. 
Very strong or kinetically inert complexes which persist from the intestine through 
plasma to the tissue have been proposed [36]. This idea, is, however not effective 
since such complexes would be unlikely to yield Cu(II) ions to the biological 











which would release the metal ions to proteins and amino acids in plasma can be 
chosen [36]. Thus the design of the ligand in this instance should be focusing upon its 
role in enhancing eu(n) absorption from the intestines [36]. 
A third alternative is to design a ligand which will not only increase absorption of 
exogenous copper, but also take advantage of the large pool of endogenous copper 
bound to serum albumin [36]. The difficulty in predicting the absorption of a 
chemical from simple diffusion theory is due to the multilayered structure of 
mammalian skin, with regions varying in their capacity to solubilise hydrophilic 
substances [37]. Previous research gave rise to the generalization that the stratum 
corneum is the main barrier to penetration of all but the most lipophilic substances. 
Substances with high lipophilicity readily penetrate the lipid environment of the 
stratum corneum, but penetrate deeper with difficulty due to poor partitioning in the 
more complex aqueous matrix of the epidennal and sub-epidennal tissue [37]. Hence, 
in this category ligands would have to be powerful enough to compete with serum 
albumin but not so powerful that they promote copper excretion [36]. 
1.3.8 Complexation and chelate effect 
There are desirable features required for a ligand for RA therapy which exploits 
eu(n) bound to serum albumin [36]. This can be made possible by designing a 
multi dentate ligand with the structural characteristics that make it effective to 
mobilize eu(n) in vivo [36]. Metal ion mobilizing agents are essentially organic 
molecules or inorganic ions which can fonn complexes with the metal ion of interest, 
thereby keeping it in solution [39]. 
Various concepts involved in metal ion complexation should be discussed prior to 
choosing a particular series of complexing agents for their potential eu(lI) mobilizing 
ability, as suggested for the treatment of RA [39]. In the simplest case, when metal 
ions are dissolved in aqueous solution they are essentially already complexes since 











Complexation can occur if the ligands are bidentate in which chelate rings are formed. 
Enhanced stability is associated with these chelate rings compared to that of similar 
complexes involving only monodentate biding [38]. This is known as chelate effect, 
first defined by Schwarznbach and is one of the oldest phenomena in chemistry [38]. 
The chelate effect defines those ligands containing two or more donor groups in such 
an arrangement that they are able to form five or six-membered rings on coordination 
to the metal ion yield complexes with substantially larger formation constants than 
those of the analogous complexes of corresponding monodentate ligands [38]. 
The chelate effect is observed in Cu(II) complexes of ethylenediamine, [Cu(en)2f+ 
which is about 107 times more stable than [Cu(NH3)4]' ignoring for the moment the 
dependence of the magnitude of the chelate effect on the chosen standard state [39]. 
Hence, the tetradentate triethylenetetramine Cu(II) complex [Cu(trien)f+, consisting 
of three contiguous or fused 5-membared rings, is a further 106 times more stable than 
[Cu(en)2f+ [39]. Cu(II) complexes of ligands which give rise to a 5,6,5 membered 
chelate system are generally more stable than their 5,5,5 chelate analogues. This is 
due to steric constrains of the three contiguous, small ring in the later [40]. However, 
in literature, it has been reported that the 5,5,5 chelate complex is more stable than the 
5,6,5 complex [40]. Increasing the number of chelate rings also enhances the stability 
[38]. Entropy increase associated with formation of chelate complexes is the simplest 
explanation for the increase stability [41]. 
It is a well-known fact of coordination chemistry that an increase in the size of the 
chelate ring above 5 usually leads to a drop in complex stability [38]. This 
observation, originally modeled in terms of entropy effects associated with the 
increase in the size of the chelate ring, is almost entirely due to favourable enthalpy 
contributions as seen in the thermodynamics of complex formation of 
ethylenediamine and propylenediamine complexes or of trimethylenediaminetetra ' 
acetic acid and ethylenediaminetetra acetic acid [40]. 
Several ligands have been investigated in our laboratory with copper(II) in trying to 
fulfil the above mentioned requirements. Sulphur could be considered an alternate 
donor atom in the ligand system as it is preferred by the softer Cu(l) ion. However, 











Because of this toxicity, ligands containing amine, imidazole and pyridine have been 
preferred. Such ligands can coordinate to a metal ion via four nitrogen atoms upon 
loss of amide protons giving rise to three chelate rings [23]. Although the unsaturated 
nitrogen donor pyridine is a stronger base than any of the saturated nitrogen in the 
gaseous phase, it is a weaker base than the saturated nitrogen donors in aqueous 
solution [23]. Thus, the order of basicity of nitrogen donors in an aqueous solution 
can be stated as follows; amino> imidazole> pyridine [23]. The unsaturated nitrogen 
donor is Sp2 hybridized, which leads to greater s character in the orbitals used for 
bonding to the metal ion and hence more covalent bonding [23]. Thus ligands where 
such hetero-aromatic donors are present can exert very high ligand field strength, 
even though their proton basicity may be significantly less than that of the Sp3_ 
hybridised saturated nitrogen donors [23]. The low proton basicity of the unsaturated 
nitrogen can be of considerable use in designing ligands, since what ultimately counts 
in many situations is not the formation constant of the metal ion with the ligand alone 
but also the relative difficulty of removing protons from the donor groups of the 
ligand so as to permit complex formation [23]. 
Since the study intends to archieve neutral eu(II) complex, the ligand has to contain 
two anionic groups or dissociable protons [23]. The 3,6,9, 12-tetra-
azatetradecanedioic acid (ttda) ligand was investigated for the elevation of RA [23]. 
However from the animal tests this ligand proved to be too powerful a chelator of 
copper, such that it was rapidly excreted, unchanged in urine [23]. Even though such 
a complex was formally neutral, being dicarboxylic acids, it was still hydrophilic and 
hence cleared from the body via the kidneys [23]. 
In order to further improve lipophilicity, the pentacyclo-undecane derived ligand 3,5-
diaminodiamido-4-oxahexacyclo dodecane (cageL) was designed [30]. This ligand 
has the amino/amido coordinating structure attached to a pentacyclo undecane 
derivative. Incorporating a rigid cage structure into bioactive compounds has its 
advantages; 
~ The cage moiety is able to cross various membranes quite efficiently due to 
their large lipophilic nature. 
~ The rigidity of the cage should increase the stability of the metal by forcing 











Research conducted by Odisitse and Jackson proved that cageL forms stable, 
lipophilic, Cu(II) complexes capable of surviving in vivo as demonstrated by 
speciation calculations using a blood-plasma model and animal experiments [30]. 
Further investigations indicated that the N,N-bis[2(2-pyridyl)-methyl]pyridine-2,6-
dicarboxamide (PrDPr) is quite selective towards Cu(II) over zinc(II) and calcium(II) 
due to the ease with which copper(II) deprotonates the amide nitrogen groups [30]. 
The rigidity of the pyridyl moiety and pyridyl nitrogen that acts as an anchor 
enhanced the ionization of the amide protons in the presence of the metal ion [30]. 
The Bis-(3-aminoethy-2-aminomethylpyridine )-oxahexacyclo dodecane (PCUL), 
under study has a structure similar to that of PrDPr, but the central pyridine in PrDPr 
is replaced by the adamentane cage moiety. PCUL has pyridyl groups which are 
found in most of the non-steroidal anti-inflammatory drugs (NSAIDs) and Cu(II)-
NSAIDs complexes are reported to be more effective than their parent compounds 
[30]. It is interesting to note that the stability of the Cu(II)-cageL complexes is greater 
than its non-cage analogue. It was anticipated that this would be the case because in 
cageL, the ligand is pre-formed in the correct conformation for metal-ion coordination 
[30]. Since the carboxylic groups reduced basicity in the pyridyl nitrogen due to its 
electron with drawing properties, they were replaced by ethyl groups in PCUL. 
Adamantanes are generally of biological and medicinal interest because they possess 
a variety of therapeutic activities such as anti-inflammatory, anti-viral, antifungal and 
antimicrobial-anticancer activities [42, 43]. Adamentanes inhibit cycloxygenase 
isoenzymes (COX-l and COX-2), preventing inflammation and pain [43]. Previous 
studies show that the presence of adamantine moiety in thiazolyl-N-substituted amides 
improved anti-inflammatory properties of this ligand, in comparison to the non-
adamantane thiazolyl-N-substituted amide. 
The coordination chemistry of 2-(aminomethyl)-pyridine (pyN) which forms part of 
the PCUL structure was explored by potentiometric analysis. The stability constants 
determined form pyN analysis was used to establish an estimation of PCUL stability 












1.3.9 Aims and objectives of the study 
The search presented above indicates that increasing the local concentration of l.m. w 
copper complexes by means of an externaly ligand could be effective in relieving the 
symptoms of rheumatoid arthritis by stimulating anti-inflammatory activity [44]. The 
ligand designed to achieve this is a pseudo-mimic of HSA (Figure 1.5) that could 
possibly compete for and mobilize endogenous reversibly bound serum albumin 
Cu(II) [44]. The same ligand would be used for exogenous administration of Cu(II) 
orally or tropically as membrane-penetrable, low molecular weight complexes [44]. 
The broad objectives of this research were to develop and investigate such a ligand, 
using the following methodology: 
~ Design, synthesis and characterization ofPCUL. 
~ Measure the formation constants of this ligand with Cu(II), Zn(II) and Ni(II) 
in aqueous solution using glass electrode potentiometry. 
~ Use a computer model of blood plasma, together with measured formation 
constants, to evaluate the plasma mobilizing ability of the ligand. 
~ Determine the structure of the Cu(II) complexes with the PCUL ligand in 
solution using UV NIS spectroscopy. 
~ Determine the sequence of protonation and where exactly the metal ion would 




PCUL 2-( aminomethyl)-pyridine glycine 
Figure 1.5: Structures ofBis-(3-aminoetby-2-aminomethylpyridine)-oxahexacyclo dodecane 
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2. GLASS ELECTRODE POTENTIOMETRY 
2.1. Introduction 
The aim of this experimental section was to determine the stability and type of 
complexes formed in solution under physiological conditions between the metal ions, 
copper(II), nickel(II), zinc(II) and the series of ligands previously described [1]. 
Several experimental methods can be utilized to investigate the chemical species that 
can potentially form in solution, for example, ultra filtration, calorimetry, solvent 
extraction, potentiometry, reaction kinetics, polarography as well as nuclear magnetic 
resonance, Raman, UV NIS and infrared spectroscopy [2]. Potentiometry is one of 
the oldest analytical methods still in wide use because of its convenience and success 
for metal complex equilibrium measurements and hence the method of choice in this 
studies [3]. 
Whole body investigations must be performed in a nutrient medium that supports the 
life of the organism. However, it is also necessary for a solution chemist to choose 
working medium conditions for the chemical model [4]. In order to determine 
stability constants at constant ionic strength, several salts are used for the test solution 
and such salts include; potassium nitrate (KN03), sodium perchlorate (NaCI04), 
sodium chloride (NaCI) and potassium chloride (KCI) [5]. However, in our 
experiments O.15molldm3 NaCI was used for the test solution. The choice of this salt 
was based on the fact that human blood is isotonic with O.l5molldm3 NaCI [5]. The 
concept of ionic strength was introduced in 1921 by Lewis and Randall who stated 
that, 'in dilute solutions' the activity coefficieJjlt of a given strong electrolyte is the 
same in all solutions of the same ionic strength [3]. Since then many workers 
attempted to keep activity coefficient constant by using solution of constant ionic 
strength [3]. 
The correct temperature for work applicable to biological systems is obviously 37°C 
[1]. However they present some practical difficulties such as evaporation from the 
test solution and condensation on the roof of the reaction vessel [1]. As most 
potentiometric determinations are carried out at 25°C, it was decided to perform all 











insulate the titration setup and being able to directly compare the results with those 
reported in literature [1]. 
The enhancement in the accuracy and predictability of the values arising from glass 
electrode potentiometry requires full mastery of the principles behind electrode 
calibration [3]. Both glass and the reference electrodes require filling solutions, 
which over the decades has evolved to be potassium chloride (KCI) as the usual first 
choice because it seems to satisfy most of the criteria, especially that of the diffusion 
rates of anion and cation being equal [6]. There is a reference electrode that embodies 
an internal electrode such as silver/silver chloride cell (silver/silver chloride being 
inside the glass membrane and provides a constant potential) and an electrolytic 
solution contained in a glass/polymer salt bridge, which surrounds the internal 
electrodes and makes electrical contact with the test solution through the liquid 
junction. The body of the glass electrode is a nonconducting glass tube sealed to a 
bulb made of special conductive glass which is a pH sensing membrane [6]. The 
body is filled with a buffered electrolyte of fixed pH value and ionic concentration 
[6]. This design ensures that the constant potentials are developed on the inner 
surface of glass membrane and on the internal reference element [6]. 
The applicability of glass electrode potentiometry in the determination of stability 
constants is only possible when the proton displacement reaction can be monitored 
[4]. The monitoring of this reaction is also possible only when the interacting ligand 
is a weak Bronsted-Lowry acid or base and the displacement reaction is in 
equilibrium [4]. 
This chapter focuses on the general theory of potentiometry as a measurement method 













2.2.1 The Stability Constant 
For simplicity, the term stability constant or formation constant will in this study refer 
to the values obtained for the overall formation constant of a metal-ligand species [7]. 
The stability constants provide a quantitative measure of the extent to which a metal 
will complex with a particular group or ligand [7]. The protonation constant is 
referred to as the chemical association of a ligand with protons [7]. 
The most accurate and reliable method for the determination of stability constants 
potentiometrically is to titrate one solution (acid or alkali) with another (of constant 
total metal and total ligand with O.lmol/dm3 alkali or O.Olmol/dm3 acid), with the 
potential being determined after each addition of the titrant [8]. The study of stability 
constants essentially involves competition between two metal ions of which one may 
be W [8]. The base titration of aqueous metal-ligand equilibria involves competition 
between the water molecules, the ligand molecules and hydrogen ions for the metal 
[8]. The hydronium ions and metal ions are also attracted by the donor ligand [8]. 
Several pre-complexation processes may be involved before the final complex species 
is formed and these would include loss of a coordination water molecule from the 
metal, followed by coordination of the ligand molecule accompanied by loss of the 
proton [8]. The overall stability constant is actually the product of stepwise stability 
constants [8]. However, the constants of the predominant chemical product species 
are selected to constitute the model that best describes the chemical system [8]. 
2.2.2 Factors that affect complex stability 
The stability constants for a number of metal complexes had been reported by 1953 
and it was feasible to ask the following question [9]: 
~ For a given ligand, how do the stability constants vary with changes in the 
central metal ion? 












Irving and Williams showed that for divalent ions of the first transition series the 
stability always follows the order: Mn <Fe < Co <Ni <Cu <Zn after reviewing all the 
data [9]. For each cation the stability increased when donor oxygen was replaced by 
donor nitrogen in either monodentate or bidentate ligands [9]. The stability increased 
with increasing number of chelate rings, but decreased with increasing ring size [9]. 
The known coordination sphere of a metal can also assist in postulating the kind of 
species that a ligand of a particular denticity will likely form with metal, which will 
also determine the extent to which the complex will be equated [9]. The 
concentration ratios of the reactants also influence the species that may predominate 
at equilibrium [7]. Polynuclear species may result from a high metal to ligand ratio 
[9]. 
2.2.3 The Potentiometric Cell 
For the quantitative evaluation of data, the Nemst equation is used between the 
experimental electromotive force (E) value and the equilibrium hydrogen ion 
concentration [Ir] delivered by a glass electrode [10]. 
Consider an electrochemical cell in which a test solution surrounding a glass electrode 
is in electrical contact with a reference electrode through a salt bridge can be 
represented as follows [11]; 
First reference second reference 
Half-cell tests solution half-cell 
(In glass electrode) (External) 
g 1 
The boundaries, g and I, respectively, indicate the glass membrane and the liquid 
junction at the inter-face between the salt bridge and the test solution. The liquid 
junction potential may be affected by [10]; 
~ pH and ionic mobility 
~ ionic strength 










~ non aqueous-aqueous boundaries 
~ the salt bridge solution 
~ temperature and pressure 
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There are four contributions to the measurable potential difference between the two 
reference electrodes. Two arise from the electrode themselves; they will have 
opposite signs and will usually be of comparable magnitudes. Their contribution 
most importantly will be independent of the composition of the test solution and so 
may be represented as a fixed combination potential, E r . 
On the other hand, the potential differences generated across the boundaries of g and I 
will depend on the activities of all the chemical species on either side of them. If 
these boundary potentials are represented by Eg and EJ, the measured emf of the cell 
is given by the following equation; 
2.1 
In the case of the liquid junction, considerable changes in the composition of the test 
solution are required to alter EJ significantly, so, for the time being, this will be 
considered as a constant. Glass electrodes, in general, are found experimentally to 
exhibit a Nernstian response over a wide range of concentration. Equation 2.1 can be 
stated as follows; 
2.2 
Where EOg is the standard glass-electrode potential at unit activity of hydrogen ions, R 
is the universal gas constant, T is the absolute temperature, F is the Faraday constant 
and {Ir} represents the hydrogen ion activity. The free hydrogen-ion activity, {Ir} 
can be expressed in terms of concentration as long as the ionic strength of the test 
solution remains constant. Hence, equation 2.3 is obtained by putting s = 2.030RTIF 
and collecting together all the constants (including the hydrogen-ion activity 











Ecell = Econst + S 10g[W] 2.3 
The activity of the hydrogen ion is defined with respect to concentration and the two 
are related by the following equation [10]; 
2.4 
where, "(I is the activity coefficient of ion "i" and Cj is the concentration of the ionic 
species "i". The departure of activity from concentration for charged species is a 
function of the ionic strength i of the solution, given by the following equation [11]. 
2.5 
where CI is the concentration of ionic species "i" and ZI is the charge on that ion [2]. 
The stability constants are also affected by temperature as represented by the Van 't 
Hoff equation [3]; 
dlnK/ dt = 4Ho / RT2 2.6 
where AHo is the standard enthalpy change of reaction and is related to Gibbs free 
energy AGo and ASo change of reaction, T is the absolute temperature in Kelvin and 
R is the natural gas constant in JK-1 mor1 [3]. 
2.2.4 Calibration of Glass Electrode System 
Before the electrode was calibrated, the glass electrode was stored in 3mol/dm3 
potassium chloride (KCI) solution which was stored in 25°C water bath. The glass 
electrode was repeatedly rinsed before each titration with boil-out distilled water and 
blotted dry. The electrode was not wiped with soft tissue paper, this was done in 
order to minimise the build up of static electricity [11]. The electrode was calibrated 




















Figure 2.1: Electromotive force (mV) versus pH at 25°C. 
The Nemstian slope was determined using commercially available reference buffer 
solutions of pH values 3.996, 7.001 and 9.012. Figure 2.1 shows a plot of 
electromotive force (emf) of each pH solution against pH. This graph gave a buffer 
line which varied between 58.83 and 59.03 which were within the acceptable working 
range of58.60 to 59.16 at 25°C. 
The final calibration of the electrode was achieved by performing strong-acid strong-
base titrations in order to calculate the value of the response intercept, EO, the value of 
13.748 for the dissociation of water (PKw) was obtained from literature and was held 
constant during the optimization procedure [12]. The values of the intercept, EO 
varied between 367.8mV and 363.499mV. The titration data obtained from strong-
acid (HCI) strong-base (NaOH) titrations were introduced into ESTA library 
programs in order to obtain more precise slope and EO values [12]. Equation 2.2 gives 
the activity ofH+, since {W} = y[W] equation 2.2 then becomes; 
aT 
Ecell = Er + EI + EgO + -lny[H+] • 
The intercept of the obtained emf of the cell from the NaOH and HCI potentiometric 












From the NaOH-HCI potentiometric titrations the Gran plots were made to check 
carbonate contamination which is shown by the curvature in the region of equivalence 
point [12]. The two Gran functions used are given as; 
Gran function = (Vi) X lO-pH ....................... before the end point 2.8 
= (Vo +Vi) xl0
pH 
...................... after the end point 2.9 
where Vo is the initial reaction vessel volume and Vi is the volume of added solution 
at the ith point of the titration. Figure 2.2 shows how carbonate contamination may be 
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Figure 2.2: Gran Function versus volume of the titrant (ml). 
The pH values used in the Gran functions at each titration point were calculated using 
the equation [12]; 
pH = -«E-EO)/s) 2.10 
2.3. Data Analysis [13]. 
The major objective in EST A is to provide a flexible tool for investigating phenomena 
associated with chemical interactions in solution and for their quantitative 
characteristics [13]. The collected data were used as input file into the ESTA file 
template in order to calculate the electrode parameters, protonation and formation 
constants [13]. The required parameters were calculated by making use of the task 
OBJE within the ESTA2A module of EST A library computer speciation modelling 











data, based upon minimization of the objective function, Uobj, with respect to emf 
[13]. The EO, [W]vesseJ, [L]vessel and [M]vessel have fixed values and therefore not 
refined. Hence the required logWs were the only values refined. The results obtained 
were used to generate ZwBar, ZM-Bar and QM-Bar curves by making use of tasks Z-
bar and Q-bar within the ESTA1 module of EST A. The task SPEC also within the 
ESTA1 module calculates the species distribution taking part in an equilibrium 
system as a function of pH of all the MpLqHr species present in solution over the pH 
range of measurement [2]. 
The reproducibility and quality of the experimental data was always checked visually 
using the formation and deprotonation functions and repeat titrations were 
superimposable in every case. 
2.3.1 Computational Data Analysis Theory [14]. 
After all the potentiometric data have been carefully collected in the laboratory, the 
stability constants which are the unknown parameters of interest are determined from 
the accurately measured known parameters. The known parameters may include 
volumes of reaction solution, temperature concentration of the solution and other 
parameters. 
For a complex formation reaction occurring between a metal, M and a protonated 
ligand, L, forming a complex MpLqHr, the eqUilibrium process is given by the 
following expression, 
2.11 
The formation constant for MpLqHr is given by the following equation according to 
the law of mass action; 
2.12 












where Ppqr is the formation constant of the species under consideration, [M]k, [L]k, 
and [H)k are concentrations of the free metal, free ligand and hydrogen ion, while p, 
q, and r are stoichiometric coefficients for metal, ligand and proton respectively. r 
can be any negative number, when r = -1, the proton is either removed from a water 
molecule (which in principle, is the same as coordination of hydroxide ligand to the 
metal ion) or from the ligand molecule occurring only in the complex, like the 
peptide-NH. 
The equilibrium conditions together with the mass balance conditions for the three 
components are given in the general case for the k tb point as follows; 
TI0M= [M]k+ l:r=, PPpqr[M]kP[L]k q[H]kr 2.14 
TI0M= [M]k+ l:r::l PPpqr[M]l[L]k q[H]kr 2.15 
TI0L = [L]k + I~ qPpqr[M]kP[L]k q[H]kr 2.16 
T k,H = [H] k + I~=t. rppqr[M)kP[L)k q[H)kr 2.17 
where T k,M, Til,l and T k,H are the analytical concentration of metal ion, ligand and 
hydrogen ion respectively. These mass balance equations are non-linear in the 
unknowns [M]k, [L]k and Ppqr and the value [H]k is obtained from the potentiometric 
measurement. The complex MpLqHr may be considered to be formed by the reaction; 
pM + qLHn H MpLqHr + (qn-r)H 2.18 
The formation constant of this reaction denoted by *Ppqr can be transformed into Ppqr 











2.3.2 ESTA (Equilibrium Simulation for Titration Analysis) Program 
Library [15]. 
41 
These programs were developed to provide a flexible, investigative tool for the 
quantitative characterization of chemical interactions in solution, especially those 
pertaining to the determination of formation constants. The program can take into 
account variations in ionic strength and the associated changes in activity coefficient. 
They also permit corrections of titration data affected by liquid-junction potentials 
and imperfect ion-selectivity of the electrode. The program library is used to 
calculate equilibrium distributions of chemical species, to analyse potentiometric 
titration data and to manipulate the titration data for a variety of other purposes. 
The main calculation are done by two types of program modules, namely, simulation 
module (ESTAl) and optimization module (ESTA2) [2]. By setting up and solving 
the mass-balance equations, ESTAI can determine, on a point-by-point basis, single 
values for almost any titration parameter. On the other hand, EST A2 determine the 
best values based on a least square procedure over a whole system of titrations. The 
other program modules are error propagation modules (EST A3) which performs a 
Monte Carlo error propagation analysis, the interative data preparation module 
(ESTAS) providing access to an extensive on-line help facility. The Gauss-Newton 
method is used to minimize the objective function, Uobj, in the EST A program. This 
objective function is optimized by the task OBJE (optimization with respect to the 
observed emf) within the EST A2 module. In contrast with the OBJT task, 
optimization is based on total concentration. Since the variations in total 
concentrations are smaller than the variation in emf, OBJT is more robust and faster 
than OBJE but less sensitive. Therefore in practice OBJT would often be used for 
initial optimization followed by OBJE for the final optimization. 
Depending on the chemical systems being investigated, for instance, the binary and 
ternary systems, the formation function (Z-bar) and the deprotonation function (Q-
bar) function are defined differently because the kinds of equilibria taking place in the 
different systems may vary depending on the number of the components that 
constitute each system. These functions are calculated by the tasks Z-bar and Q-bar 











The task SPEC within ESTAI module calculates the distribution of species taking 
part in an equilibrium system as a function of pH of the solution [16]. 
2.3.3 The Objective function (Uobj) [15]. 
The objective function to be minimized by the interactive refmement of the set of 
stability constants is given by; 
Uobj = (N-npr1 ~ ne-
1 ~ Wn (Ynobs_ YncalC)2 
where Yn OM and Yn calc may be either EMFn or Tn 
Wn is the weight applied at each point 
N is the total number of experimental titration points and 
Np is the number of parameters to be optimized 
2.19 
A Gauss-Newton method is the most frequent approach used for minimizing U and 
this has been adopted in EST A as the main means of optimization. The objective 
function assumes that the function is quadratic with respect to all the parameters; 
hence U obj can be expressed as in the following equation; 
2.20 
where a and b are Gauss-Newton quadratic parameter vectors, p is optimization 
parameter vector, pt transpose of p. 











2.3.4 The Formation Function (Z-bar) and Deprotonation Function (Q-bar) [15]. 
Two important functions; the Z-bar and the Q-bar calculated from the titration data 
within the EST A programs. They are defined differently depending on the presence 
or absence of a metal ion. 
In the absence of a metal ion the protonation fuflction is expressed as; 
ZH-bar = (TH-H + OH) / TL 2.22 
where THis the total hydrogen ion concentration, T L is the total ligand concentration 
and OH = Kw / [H]. ZH may be plotted against pH and is the average number of 
hydrogen ions bound to the ligand at each pH. 
The average number of ligands bound per metal ion at each concentration of the 
ligand is measured by the complex formation function, ZM-bar and is given by the 
following equation; 
ZM-bar = (TL - (L]) / TM 2.23 
where, T L, T M, and L are the total ligand, total metal and free ligand respectively. The 
ZM-bar function applies only to mononuclear binary complexes. A plot of ZM-bar 
against the negative logarithm of free ligand concentration, defined as pL gives a 
pictorial representation of the eqUilibria taking place. The average number of protons 
released per metal ion, as a result of complexation is determined by the deprotonation 
function, QM-bar and is defined according to the equation; 
2.24 
where TH and TM are the total proton and metal concentrations respectively and TH* 
is the calculated total concentration of protons that would be necessary to give rise to 













where [OH] = Kw / [H] and the summation is the overall protonated ligand species. 
In binary systems, a formation function represents the number of protons that would 
be on the ligand in the absence of the metal ion, is defined by; 
nbar = (TH* - [H] + [OH]) / TL 2.26 
The average number of dissociable protons in a complex would be given as in the 
following equation; 
F = qnbar - QbarP 2.27 
A set of theoretical titration data is generated by the selected and refined model. The 
agreement between the experimental plot and the theoretical plot is an indication of 
the validity of the proposed chemical model, a process termed pseudo-plotting. 
2.3.5 Data Error Analysis [15]. 
In potentiometric titrations the determination of the protonation and stability constants 
requires minimal experimental errors. The optimization of stability constants may be 
affected by the magnitude of random and systematic errors inherent in the system. 
Hence a thorough examination of these errors has been done by studying a well 
known system for experimentally generated error, or by varying the reaction 
conditions for a particular system and observing its reproducibility. Random errors 
usually cancel each other out as the number of titration points increase as opposed to 












The neglect of weighting can undoubtedly, have very detrimental consequences [16]. 
As anyone who attempts to use an unweighted objective function based on residuals 
in emf soon discovers, manifestly bad results can be obtained because of the excessive 
influence of unbuffered regions in the data (for example, the points that occur near 
end-points, where small errors in titration volumes, etc.,) produce large errors in emf 
[16]. The purpose of weighting is to reduce, as much as possible, the adverse 
influences on optimized parameters that arise because errors in values held constant 
during the calculation tend to propagate differently at different points [16]. To obtain 
unbiased results, the data ought to be weighted so that those points likely to be 
distorted most by the experimental error are correspondingly reduced in their effects 
on the optimized values of parameters [16]. 
Basically, weighting takes into account the fact that some of the titration points will 
be more reliable than others and hence relatively greater importance should be placed 
on these on the optimization process [17]. Therefore large residual of an unreliable 
data point will not tend to be reduced in favour of increasing other smaller residuals 
less affected by such errors [17]. 
The weight of the qth residual at the nth titration point may be expressed as; 
2.28 
where Y nq obs and Y nq calc are observed and calculated variables of the qth residual at the 
nth point respectively [16]. op is the standard deviation in the parameter p to be 
optimized [16]. 
The goodness of fit between experimental and calculated data from the refined set of 












The R-factor can be compared to R-Iim which is an indication of the best possible fit 
that can be obtained under the conditions that have been imposed by the set of 
experimental errors [16]. The R-Iim is calculated from; 
2.30 
The Rlim H is the best possible R value based on the random error in the analytical data 
and the number of variables [16]. Thus the closer RrH gets to Rlim H the better the 
agreement between the theoretical model and the experimental data [16]. However, 
since the theory is strictly valid for random errors only, which is often not the case in 
actual titrations, the R-factor can become less than the Rlim H and in such a case the 
model is within the maximum allowed experimental error [16]. 
The computational procedure employed for the determination of protonation and 
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Figure 2.3: Flow chat describing the procedure for the determination of the protonation and 














The procedure developed by Sillen and his colleagues over two decades ago are still 
widely accepted as the most accurate way of determining formation constants 
potentiometrically [18]. Solutions containing different metal to ligand concentrations 
and ratios are titrated potentiometrically with standardized strong base [18]. These 
titrations served to check the reversibility and reproducibility of each system, as well 
as to obtain protonation constants and electrode parameter values [19]. The data 
collected from these titrations were analysed by EST A suit of programs to obtain the 
best fit of formation constants [20]. The resulting models were used to generate 
theoretical formation curves which could be compared with experimental curves [20]. 
2.4.2 Preparation and standardisation of solutions 
In this study carbon dioxide must be excluded because it will react with NaOH to give 
bicarbonates and carbonates as shown in equations 2.31 and 2.32 respectively [21]. 
C02 + NaOH --J NaHC03 
Sodium Bicarbonate 




Therefore this will render the potentiometric results inaccurate. In order to exclude 
carbon dioxide in solutions, the following procedures were used: 
~ Apart from ethylenediamine tetraacetic acid (EDTA), all solutions were 
prepared with NaCI as background electrolyte at an ionic strength of 
0.15moVdm3• 
~ All solutions were prepared using glass distilled deionised water which had 
been boiled to remove carbon dioxide and cooled in a container protected by 











~ The volumetric flasks were calibrated with distilled deionised boiled-water 
allowing for the Archimedes effect on standard weights, the volumetric 
expansion of glass and density changes of the water temperature [19]. 
~ All chemicals were used with no further purification and were dried in a 
dessicator prior to preparation of the solutions. 
2.4.3 Preparation of Stock base solution (NaOH) 
O.lmol/dm3 NaOH solutions were prepared under a nitrogen gas atmosphere to a 
concentration of O.lmol/dm3 from Merck ampoule (l.09959-Totrisol) [3]. This 
solution was standardised against recrystallized potassium hydrogen phthalate (KHP) 
using the Gran Method [22]. 
2.4.4 Preparation of Stock acid solution (HCI) 
O.lmol/dm3 and O.Olmol/dm3 Hel solutions were prepared from a Merck ampoule 
(l.09973-Titrisol) in a background electrolyte [22]. O.Olmol/dm3 Hel solution was 
standardised by titrating against the standardised NaOH using the Gran Method [22]. 
This titration data was also used to determine carbonate concentration ofNaOH titrant 
solution by making use of the Gran method. The carbonate concentration will be 
shown by the curvature in the Gran plot. 
2.4.5 Preparation of Stock Metal(II) ion solutions 
The metal solutions were made up from the dehydrated chloride salt, as chloride was 
the choice of the background electrolyte. These solutions were then standardized 
against EDTA using Fast Sulphon Black (FSB), murexide and solo chrome black as 
indicators for copper(II), nickel(II) and zinc(II) respectively according to the 
procedure given in Vogel [23]. 
The concentrations of the solutions varied between O.0046mol/dm3 and 
O.0117mol/dm3• In-order to prevent hydrolysis of the metal ions standardised 
O.OOlmol/dm3 Hel was added into the metal ion solutions. The metal hydroxide 












2.4.6 Preparation of Stock Ligand Solutions 
Solutions of ligands under study were prepared by dissolving accurately weighed 
samples of PCUL and PyN in a background electrolyte. The concentration of these 
solutions was estimated based on the mass of each of the two ligands and were found 
to be 0.OI80mol/dm3 and 0.0200molldm3 for PCUL and pyN-N respectively. 
2.4.7 Preparation of Stock Glycine solution 
For each titration the required amounts of the ligands was weighed and allowed to 
dissolve in 0.I5molldm3 NaCI solution in a reaction flask under N2 atmosphere [11]. 
2.4.8 Equipment 
The potentiometric titrations were performed under an inert atmosphere of purified 
nitrogen gas, at 25°C, using a Radiometer PHM 84pH meter and Metrohrn 665 
Dosimet burette which were linked and controlled by a computer [24]. The calibrated 
combined pH glass electrode of 3M KCI internal filling solution was connected to the 
pH meter [24]. The electrode was immersed in a solution contained in a double-
walled titration vessel, which was kept at constant temperature of 25°C by circulating 
water from a constant temperature thermostat bath [24]. 
The titrant solution T was delivered to the titrated solution S through an immersed 
capillary tip from a Metrohrn Dosimat 665 piston burette using a Pascal program 
developed in this laboratory, to monitor the pH and the volume of T added at each 
titration point [25]. During titrations these solutions were stirred by Teflon magnetic 
stirrer bar, which allows a homogenous solution to be obtained giving a fairly fast 
response time but all calibration procedures were carried out at the same stirring rate. 
Care should be taken to ensure that the magnetic follower does not bump when 
rotating and thereby damaging the electrode [25]. 
The reaction solution was protected from the intrusion of atmospheric oxygen and 
carbon dioxide by passing a continuous flow of high purity stream over it throughout 
the titration. A gas bubbler attached to the gas outlet from the titration vessel 
prevented back diffusion [25]. To ensure the reproducibility of the titration data, all 











introduced into the titration solution it was passed through five traps which included 
[26,27]: 
~ 50% potassium hydroxide, to remove traces of carbon dioxide 
~ Fieser's solution consisting of 20g potassium hydroxide, 2g sodium 
anthraquinone-2-sulphonate and 15g sodium dithionite in 100mi water to 
remove traces of oxygen 
~ Glass wool 
~ Distilled water 
~ Background electrode of 0.15 mol/dm3 to humidify the inert atmosphere 
2.4.9 Data Analysis 
The major objective in EST A is to provide a flexible tool for investigating phenomena 
associated with chemical interactions in solution and for their quantitative 
characteristics [11]. The collected data were used as input file into the ESTA file 
template in order to calculate the electrode parameters, protonation and formation 
constants [2, 11]. The required parameters were calculated by making use of the task 
OBJE within the EST A2A module of EST A library computer speciation modelling 
programs [2]. The analysis was performed by fitting these constants to the titration 
data, based upon minimization of the objective function, Uobj, with respect to emf [2]. 
The EO, [Wlvesset. [L ] vessel and [M]vessel have fixed values and therefore not refined. 
Hence the required logp's were the only values refined. The results obtained were 
used to generate ZwBar, ZM-Bar and QM-Bar curves by making use of tasks Z-bar and 
Q-bar within the ESTA1 module of EST A. 
The reproducibility and quality of the experimental data was always checked visually 
using the formation and deprotonation functions and repeat titrations were 
superimposable in every case [25]. It was rather difficult to work with our PCUL 
ligand because only --D.2123g was provided which made a stock solution of 30m I and 
therefore small solution volumes were used for each experiment, hence high errors 











2.5 Results and discussion 
2.5.1 Glycine system 
The EST A program library of computer speciation modelling programs was used to 
determine the protonation and stability constants [20]. The task OBJT was used with 
all the estimated stability constants for a more general adjustment, the output gave 
modified guesses and was optimised together with the acid concentration using the 
task OBJE to give the final values of the stability constants and the acid concentration 
describing the system [20]. 
2.5.1.1 Glycine protonation 
H-glycine equilibria protonation constants were evaluated in the pH range of2 -11. 
Figure 2.4 shows proton formation function, Zwbar plotted against pH for glycine. 
The Zwbar function rises slightly above 1 for this system indicating a stepwise 
protonation of two sites of which only one is fully protonated in the pH range studied. 
Glycine like all the amino acids in their pure state exists as a dipolar ion, a 
zwitterionic form being more favoured energetically both in solution and in solid state 
[11]. Depending on the pH of the aqueous solution, glycine exists as a zwitterion, the 
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Figure 2.4: Protonation curves, Zwbar against pH for glycine at 25°C in O.15moVdm3 (Cn Na+. 











Theoretically, the Zwbar should rise and level off towards the limiting value of 1 for 
mononuclear LH species formation indicating the presence of LH as a major species. 
Figure 2.4 is in good agreement with this theory, the levelling off of the curve at 1 
indicates the protonated amino group which begins to lose a proton. The carboxyl 
deprotonation occurs at low pH where the accuracy of pH measurement is also low 
thus bringing about a slightly higher standard deviation than that of amino group [25]. 
Table 2.1: logBpqr of H-glycine system detennined at 25°C in 0.15moVdm3(Cl") Na +. std Dev denotes 
standard deviation in logBpqr. Rl is the Hamilton R-factor and Rum H its limit. The general formula of a 
complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Ligand Pqr log8pq. stdDev logK Rt R.imH nT (np) Literature;tll 
H-glycine o I 1 9.56 0.021 9.56 0.017 0.039 2 (102) 9.59 
012 11.94 0.093 2.38 2.37 
The complete overlap of the calculated and the observed Zwbar plots confirmed the 
overall protonation constants. The protonation constants determined by ESTA suit of 
programs (shown in Table 2.1) for glycine are pKl = 9.56 and pK2 = 2.38 and are 
assigned for the amino group and the carboxyl group respectively [25]. The standard 
deviations are relatively small, the R-factor is less than its limit thus giving more 
confidence to this model. 
2.5.1.2 Cu(II)-glycine complexation 
The 10gPpqr obtained from EST A were entered into the input files of the tasks Z-bar 
and Q-bar of ESTA 1 module to give ZM-bar and Q-bar plots respectively [25]. ZM-
bar measures the average number of ligands bound per metal ion due to complexation. 
This function is plotted against the negative logarithm of the free ligand concentration 
(PL) [25]. 
Figure 2.5 shows a plot of ZM-bar as a function of pL for the Cu(II)-glycine system. 
The existence of bis complex of 1:2 M: L ratio is indicated by the levelling off of the 
function at the value of 2. In this system copper(II) coordinates with two molecules of 
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Figure 2.5: Formation function curve, ZM-bar against pL for the Cu(II)-glycine at 25°C in 
O.l5moVdm3 (Cn Na+. M:L ratio 1:2 is displayed. The solid line represents the 
theoretical curve. 
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The deprotonation function, Q-bar, which indicates the average number of protons 
released upon complexation, is plotted against the pH of the solution [25]. This 
function is compared with n-bar function which measures the average number of 
protons that would be bound to the ligand in the absence of complexation [25]. 
In Figure 2.6, the deprotonation curve function rapidly rises, intersecting the n-bar at a 
value of 1 a pH 4. At this pH the n-bar = 1 indicating that the glycine has only one 
dissociable proton and no MLH_l or and MLH2 species formed. From the results 
given in Table 2.2, the divalent copper forms ML and ML2 species with log~pqo'S 8.03 
and 14.67 respectively. The deprotonation curve function continues to rise reaching a 
maximum value and levelling off at 2 at pH range 5-9. The rising of the Q-bar curve 
function is due to the formation of the hydroxo species 1 1 -1. Above pH 9.3, the Q-
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Figure 2.6: Deprotonation function curve, Q-bar against pH for the Cu(II)-glycine at 25°C in 
O.l5mol/dm3 (Cn Na+. M:L ratio 1:2 is displayed. The solid line represents the 
theoretical curve. 
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The results obtained for the Cu(II)-glycine system are similar to those obtained in 
literature [28]. Table 2.2 also shows the hydroxo species which was never measured 
before. The low standard deviation, R-factor is less than its limit thus indicating that 
the model is within the maximum allowed experimental error. The agreement 
between the theoretical and the experimental curve gave confidence to the proposed 
model. 
Table 2.2: log/3pqr of the Cu(II)-glycine system determined at 25°C in 0.15 mol/dm3 (Cn Na+. std 
Dev denotes standard deviation in log/3pqr, Rf
H is the Hamilton R-factor and Rum H its limit. The general 
formula of a complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Metal-ligand pqr log/3pqr std Dev Rt RumH nT (np) Literature2 ! 
complex 
Cu(II)-gly 110 8.03 0.008 0.006 0.Q1 3 (273) 8.20 
120 14.67 0.Q1 15.07 
1 1 -1 0.01l 0.02 
Figure 2.7 shows calculated species distribution curves for the Cu(II)-glycine system. 
According to the species distribution plot for Cu(II)-glycine system, complexation 
starts at pH ~2 forming ML species until pH 4.5 [25]. The formation of the 
predominant species, ML2 begins at pH~2.9. Beyond pH 7 the solution contains 
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Figure 2.7: Species distribution curves of the Cu(II)-glycine as a function of pH. 
2.5.1.3 Ni(lI)-glycine complexation 
Figure 2.8 shows a plot of ZM-bar as a function of pL for the Ni(II)-glycine system. 
The curves are not superimposable indicating the presence of species other than 
simple mononuclear species [25]. The splitting is such that the bottom curve is for 
M:L ratio 1:1 and the top one for 1:3. The fanning back of the complex formation 
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Figure 2.8: Formation function curve, ZM-bar against pL for the Ni(II)-glycine at 25°C in 
O.l5moVdm3 (Cr) Na+. M: L ratios 1:1, 1:2 and 1:3 are displayed. The solid line 
represents the theoretical curve. 
Figure 2.9 shows a plot of Q-bar as a function of pH for the Ni(II)-glycine system. At 
pH value less than 4, the deprotonation function, Q-bar is zero indicating that no 
protons have been displaced due to complexation [25]. The n-bar has a value of about 











function curves rapidly rise to intersect the protonation curve, n-bar at pH ~5. The Q-
bar curve function rapidly rises to a value of 2 at pH range 7 to 8.4; this indicates that 
in basic conditions the predominant species in solution is MLH_1• The curves are not 
superimposable and intersect the n-bar curve at pH--6 reaching a maximum value of 
~1.9 at pH 7. Above this pH, the Q-bar curves run parallel to the protonation curve 
and then levels off at a value of 1.5 in a strongly alkaline solution indicating that no 
further complexation occurs at this point. The splitting is such that the bottom curve 
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Figure 2.9: Deprotonation function curve, Q-bar against pH for the Ni(II)-glycine at 25°C in 
0.15mol/dm3 (Cl") Na+. M: L ratios 1:1, 1:2 and 1:3 are displayed. The solid 
line represents the theoretical curve. 
logSpqr values for the Ni(II)-glycine system are given in Table 2.3. The R-factor is 
slightly higher than its limit indicating that it is not statiscally possible to improve the 
model. The similarity between the experimental and the literature results supported 
the proposed model. 
Table 2.3: log[3pqr of the Ni(II)-glycine system determined at 25°C in 0.15 mol/dm3 (Cl") Na +. std 
Dev denotes standard deviation in log[3pq., RfH is the Hamilton R-factor and Rum H its limit. The general 
formula of a complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Metal-ligand complex pqr log(3pqr stdDEV Rt Rlimt1 nT (np) LiteratureL.!I 
Ni(II)-gly 1 1 0 5.05 0.008 0.04 0.02 8 (389) 5.59 
120 10.09 0.01 10.24 











Figure 2.10 shows calculated species distribution curves for the Ni(II)-glycine system. 
ML formation starts at pH 3 as indicated by Figure 2.10. The formation of the ML 
and ML2 species pattern follows that of Cu(II)-glycine system. However, it is 
important to note that the stability constants obtained for the Cu(II)-glycine system 
are higher than those obtained for the Ni(II)-system. This is confirmed by the 
percentage formation of the ML species which is formed, at 70% for the Cu(II)-
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Figure 2.10: Species distribution curves of the Ni(II)-glycine as a function of pH. 
2.5.1.4 Zn(II)-glycine complexation 
Figure 2.11 shows a plot of ZM-bar function curve against pL for the Zn(II)-glycine 
system. The ML species are not the only species present in solution and this is 
indicated by the ZM-bar curve function not levelling off at 1 as found for the Ni(II)-
glycine system. The fanning back of the complex formation function at pL 3.2 is an 





















Figure 2.11: Formation function curve, ZM-bar against pL for the Zn(II)-glycine at 25°C in 
O.15moVdm3 (Cn Na +. M:L ratios 1 :3, 1:4 are displayed. The solid line represents 
theoretical curve. 
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Figure 2.12 shows a plot of deprotonation curve function, Q-bar against pH for the 
Zn(II)-glycine system. Similar to the Ni(II)-glycine system, the n-bar have value of ~ 1 
at pH 4 confirming that glycine is still protonated at low pH. At pH >4.5, Q-bar 
rapidly rises to intersect the n-bar at 1. Between pH 7 to 8 the Q-bar curves rapidly 
rise to a maximum value of 2 indicating that at high pH the predominant species in 
solution is ML2. At pH >8.5, the Q-bar curves run parallel to the n-bar curve 
indicating that no further complexation take place beyond this pH. The R-factor is 
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Figure 2.12: Deprotonation function curve, Q-bar against pH for the Zn(II)-glycine at 25°C in 
O.15moVdm3 (Cn Na+. M:L ratios 1:3, 1:4 are displayed. The solid line represents 











Table 2.4 shows three species obtained in the complexation of Zn(II) with glycine 
ligand together with their stability constants. The standard deviations are reasonably 
low and are lower than those obtained in the Zn(II)-glycine system. The obtained 
logBpqr for Zn(II)-glycine system are similar to literature values. The R-factor:::::: R-lim 
therefore it is not statiscally possible to improve this model. 
Table 2.4: logppqr of the Zn(II)-glycine system determined at 25°C in 0.15 mol/dm3 (Cn Na+. std 
Dev denotes standard deviation in logf\,q" Rf
H is the Hamilton R-factor and Rrun H its limit. The general 
formula of a complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Metal-ligand complex Pqr logPpqr std Dev Rt RlimH nT (np) Literature.lll 
Zn(II)-gly 1 1 0 4.931 0.007 0.026 0.018 4 (210) 4.90 
120 9.113 0.007 8.96 
1 1 -1 -0.309 0.012 
The calculated species distribution curves for the Zn(II)-glycine system are given in 
Figure 2.13. The formation of the ML species begins at pH 3.5. It is important to 
note that the formation of the ML species for Zn(II)-glycine system follows that of 
Cu(II)-glycine and Ni(II)-glycine systems. However, there is a difference in the 
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Figure 2.13: Species distribution curves of the Zn(II)-glycine as a function of pH. 
From Table 2.1, the pKa values obtained for H-glycine systems are in close agreement 
with those obtained in literature. Also from Tables; 2.2, 2.3, and 2.4 the obtained 
deprotonation constants are in close agreement with those obtained in literature. The 
variation is due to the fact that our experiments were performed at 25°C in 0.15 











0.1 mol/dm3 (Cn Na+[28]. The glycine potentiometric studies were done to directly 
compare our results with those reported in literature in order to validate the proposed 
experimental procedure. 
2.5.2 pyN system 
The determination of the protonation and stability constants for pyN system followed 
the same experimental procedure as that of the glycine system. For analysis, the 
potentiometric data was entered into the EST A library of computer speciation 
modelling programs [25]. 
2.5.2.1 pyN-protonation 
H-pyN equilibria protonation constants were evaluated in the pH range of 2 -11. 
Figure 2.14 shows a plot of Zwbar against pH which indicates that pyN contains one 
measurable protonation site as indicated by the levelling off of the Zwbar function at 
1 at pH 5. This indicates that 1 proton is added to the ligand, resulting in a mono-
protonated ligand at low pH. Above pH 7 the predominant species is pyN while 
below this pH the predominant species is pyNH+. The stability constants given in 
Table 2.5 are similar to those obtained by Martell [28]. As with glycine system, the 
slight discrepancy is due to the ionic strength of 0.15mol/dm3 (Cn Na+ used in 
literature. 
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Figure 2.14: Protonation curves, ZH-bar against pH for pyN at 25°C in 0.15 moVdm3 (Cn Na+. 











The complete overlap of the calculated and the observed Zwbar plots confirmed the 
overall protonation constants. The protonation constants determined by EST A suite of 
programs for pyN are logKI = 8.66 and pK2 = 2.20 as shown in Table 2.5. These 
stability constants are assigned for the nitrogen in the amine group and nitrogen in the 
pyridyl group respectively. The low pKa value of the second protonation is due to the 
electronic repulsion effect and base weakening effect of the protonated amine [24]. 
Table 2.5: log~ ofH-pyN system determined at 25°C in 0.15 moVdm3 (Cn Na+. std Dev denotes 
standard deviation in log~, RcH is the Hamilton R-factor and Rum H its limit. The general formula of a 
complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Ligand pqr log~ stdDev logK Rctt Rum nT (np) Literature"~ 
H-pyN o 1 1 8.66 0.02 8.66 0.04 0.002 2 (122) 8.61 
012 10.86 0.05 2.20 2.00 
The R-factor is greater than R-lim, however since the experimental and the theoretical 
protonation constants are relatively similar, the proposed model was considered 
reasonable correct. 
2.5.2.2 Cu(II)-pyN complexation 
Figure 2.15 shows a plot of complex formation function ZM-bar plotted against the 
negative logarithm of the free ligand concentration (PL). This function rapidly rises 
to 1.5 at low pL value. The fact that the ZM-bar does not level off at 1 indicates that: 
~ Mononuclear species are not the only species in solution. 
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Figure 2.1S: Formation function curve, ZM-bar against pL for the Cu(II)-pyN at 25°C in 
O.15moVdm3 (Cr) Na+. M:L ratio 1:2 is displayed. The solid line represents the 
theoretical curve. 
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The deprotonation function, Q-bar is plotted against pH as shown by Figure 2.16. 
This function is plotted in conjunction with n-bar, which indicates the amount of 
protons that would be bound to the ligand in absences of the metal. Complexation 
with Cu(II) begins at pH 2.5. The Q-bar curve function rapidly rises to intersect the 
n-bar at Q-bar value of 1 at pH 3.5 indicating that a single proton is lost upon Cu(II)-
pyN complexation, thus resulting in simultaneous formation of 1 1 0 and 1 2 0 with 
log~pqr's 9.71 and 16.13 respectively as given in Table 2.6. The Q-bar curve function 
continuously increases reaching a Q-bar value of 1.8 at pH 6.5 indicating that the 
ligand lost a total of two protons and the predominant species at this pH is 1 2 O. 
Beyond pH 6.5 no further complexation takes place as the Q-bar curve function runs 
parallel to the n-bar. 
At pH range 2.7-3.5 there is good agreement between the theoretical and the 
experimental curves. However, as the Q-bar rises with increasing pH, the agreement 
between these two curves slightly differs. This is of no concern as at this pH 
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Figure 2.16: Deprotonation function curve, Q-bar against pH for the Cu(II)-pyN at 25°C in 
O.15moVdm3 (Cn Na+. M:L ratio 1:2 is displayed. The solid line represents the 
theoretical curve. 
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The fonnation of 1 1 0 and 1 2 0 is confinned by the species distribution plot against 
pH given in Figure 2.17, 70% of 1 1 0 species is fonned at pH 3.5 and at pH 6, 100% 
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Figure 2.17: Species distribution curves ofCu(II)-pyN as a function of pH. 
The two species detennined by EST A suite of programs are given in Table 2.6. From 
this table we can see that the experimental first 10gPpqr is similar to the literature value 
while the second 10gPpqr's slightly differ with each other. This discrepancy may be 
attributed to the fact that Martell conducted experiments at 0.1 mol/dm3 (Cn Na+. The 
low standard deviations in 10gPpqr's led confidence to the results. It is not statiscally 











Table 2.6: log~r of the Cu(II)-pyN system determined at 25°C in 0.15 moVdm3 (Cn Na+. std Dev 
denotes standard deviation in log~, Rr is the Hamilton R-factor and Rmn H its limit. The general 
formula of a complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Metal-ligand complex pqr log~r std Dev Rt ~imH nT (np) LiteraturezlI 
Cu(II)-pyN 1 1 0 9.71 0.01 0.018 0.012 2 (60) 9.50 
120 16.l3 0.01 17.20 
1 1 -1 -0.01 0.02 
2.5.2.3 Ni(II)-pyN complexation 
Figure 2.18 shows a plot of ZM-bar against the logarithm of free ligand concentration. 
From this plot, the ZM-bar curve function reaches a maximum of -1.7 at pL -5.5 
indicating that about two protons would be bound per metal ion due to complexation. 
The ZM-bar curve function does not level off at 1, indicating that mononuclear species 
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Figure 2.18: Formation function curve, ZM-bar against pL for the Ni(II)-pyN at 25°C in 
0.15moVdm3 (Cn Na+. M:L ratio 1:2 is displayed. The solid line represents the 
theoretical curve 
The deprotonation function in Figure 2.19 shows that at pH -2.13 the function is not 
zero, indicating that complexation has already started. The species distribution curve 
versus pH in Figure 2.20 indicates that complexation occurs at the onset of the 
titration at pH 1.9. The deprotonation curve function rises intersecting the n-bar at Q-
bar value of -1 at pH 5 losing one proton thus forming 1 1 0 species, however Figure 
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Figure 2.19: Deprotonation function curves, Q-bar against pH for the Ni(II)-pyN at 25°C in 
O.15mol/drn3 (Cn Na+. M:L ratio: 1: 2 is displayed. The solid line represents the 
theoretical curve. 
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The Q-bar curve function continues to rise, reaching a maximum of 1.7 at pH 6.4 
indicating that almost two protons are lost upon Ni(II)-pyN complexation thus leading 
to the simultaneous formation ofML2 species. Figure 2.20 shows that 76% of 1 20 is 
formed in solution at pH ~ 7.4. No further complexation occurs beyond pH 6.5 as the 
Q-bar curve runs parallel to the n-bar curve. Also at pH 6.5 the theoretical and the 
experimental curves differs slightly from each other. However, this occurs at the 
buffered region after complexation process has been completed, therefore this is not 
of concern. The formation of ML(OH) species occurs at pH 9.32. However, only 















2.00 .. 00 4.00 •• 00 •• 00 7.00 8.00 •• 00 
pH 











The EST A suite of programs gave the deprotonation constants shown in Table 2.7. 
The experimental LogPpqr's differs from those obtained in literature. This may be due 
to the fact that Martell performed experiment at 0.1 mol/dm3 (Cn Na+ [28]. The 
standard deviations are relatively low, the agreement between the theoretical and 
experimental curve function at pH 4.5-5.5 supported to the proposed model. 
Table 2.7: log~ of the Ni(II)-pyN system detennined at 25°C in 0.15 mol/dm3 (Cn Na+. std Dev 
denotes standard deviation in log~, Rl is the Hamilton R-factor and Rum H its limit. The general 
fonnula ofa complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Metal-ligand complex pqr log~ std Dev R.c" Rtimn nT (np) Literature"" 
Ni(II)-pyN 1 10 6.136 0.04 0.031 0.013 2(70) 7.11 
120 12.26 0.03 13.34 
1 1 -1 2.30 0.06 
2.5.2.3 Zn(II)-pyN complexation 
Figure 2.21 gives a plot of ZM-bar curve function against free ligand concentration. 
ZM-bar curve function reaches a maximum of -1.7 at pL 4.5. As for the Cu(II)-pyN 
and Ni(II)-pyN systems, this indicates that two ligands would be bound per metal ion 
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Figure 2.21: Fonnation function curve, ZM-bar against pL for the Zn(II)-pyN at 25°C in 












Figure 2.22 shows the complexation pattern of Zn(II)-pyN system. From this graph, 
the complexation process begins at pH 2.5 for this system. At pH -6.6 the Q-bar 
curve function intersect the n-bar curve function at 1. Indicating that 1 proton is lost 
upon Zn(II)-pyN complexation and the predominant species at this pH is ML. The Q-
bar curve function continues to rise reaching a maximum of 1.3 at pH 7.8 thus 
indicating a slight formation of ML2 species. The Q-bar curve function then run 
parallel to the n-bar, indicating that no further complexation occurs beyond pH 7.8. 
It is important to note that a good agreement between the theoretical and the 
experimental curves is observed for Zn(II)-pyN system at pH 2.5-7.4. At pH >9.3 the 
Q-bar curve function rises again reaching -1.7, indicating the formation of ML(OH) 
species in this alkaline region. Rising of the Q-bar to -1.7 indicates that the ligand 
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Figure 2.22: Deprotonation function curves, Q-bar against pH for the Zn(II)-pyN at 25°C in 
O.15mol/dm3 (Cn Na+. M:L ratio: I: 2 is displayed. The solid line represents the 
theoretical curve. 
The calculated species distribution curves for the Zn(II)-pyN system are given in 
Figure 2.23. The formation of the ML species starts at the beginning of the titration 
process at pH 2.7 and continues until pH 8.7. The formation ofML2 species begins at 
pH 4.7 while that ofML species begins at pH 2.7 and continues until pH 8.7. At pH 
6.4, ML species reaches 53% formation while ML2 species reaches 59% formation at 
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Figure 2.23: Species distribution curves of the Zn(II)-pyN as a function of pH. 
The three species obtained for Zn(II)-pyN system are given in Table 2.8. The 
similarities between the experimenta1logppqr'S values and the literature ones, and the 
low standard deviations gave confidence to the results. The theoretical and the 
experimenta1logppqr are similar and the standard deviations are relatively low and this 
led confidence to the results. 
Table 2.8: log~r of the Zn(II)-pyN system detennined at 25°C in 0.15 moVdm3 (Cn Na+. std Dev 
denotes standard deviation in log~, ReH is the Hamilton R-factor and Rtim H its limit. The general 
fonnula of a complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Metal-ligand complex pqr log~r std Dev Re" RtiJn" nT(np) Literature-'B 
Zn(II)-pyN 110 5.282 0.02 0.019 0.01l 4(132) 5.28 
120 9.393 0.02 9.44 
1 1 -1 0.323 0.02 
The results obtained for Zn(II)-pyN complex were satisfactory, hence validating 
comparison the use of pyN system as model system with PCUL system. pyN was 
included in this study since it forms part of the PCUL (ligand of interest) structure. 
The results from pyN potentiometry were compared with literature and gave us an 











2.5.3. PCUL system 
It was rather difficult to perform studies on the PCUL system because only 0.21230g 
of the ligand was provided. Also it was a hydro scopic oil which made accurate 
weighing of the ligand impossible. For these reasons, a 30ml stock ligand solution 
was prepared and, used for all experiments. Working with small volumes increased 
the associated error and meant that fewer titrations could be performed as compared 
to the glycine and pyN systems. For these reasons the standard deviations are quite 
high. 
The determination of the protonation and stability constants for PCUL system 
followed the same experimental procedure as that of the glycine and pyN systems. 
2.5.3.1 PCUL-protonation 
PCUL equilibria protonation constants were evaluated in the pH range of 2 -11. The 
complete overlap of the calculated and the observed Zwbar plots confIrmed the 
overall protonation constants. PCUL has three pKa values corresponding to the 
nitrogens in the amines and the one corresponding to the nitrogen of the pyridyl 
group. 
The Zwbar function in Figure 2.24 shows only one inflection point because the 
protonation constants of these amine groups are so close and that they are titrated 
virtually simultaneously. The difference of 0.86 log units between pKI and pK2 
indicates an electronic repulsion on addition of a proton to a charged species or rather 
to an already protonated molecule. The fourth protonation constant could not be 
determined because complete protonation of the pyridyl nitrogen occur below the 
reliable measurable pH range of our glass electrode [24]. 
From Figure 2.24, the protonation curve Zwbar versus pH obtained for PCUL is 
sigmoidal in shape with limiting Zwbar value of 2.5. It is important to note that the 
protonation constants obtained for PCUL are similar to those obtained for pyN as 
expected, since pyN forms part of the PCUL structure. At pH lower than 3 the 
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Figure 2.24: Fonnation function curves, ZH-bar against pH for PCUL at 25°C in 0.15mol/elm3 
(Cl') Na+. The solid line represents the theoretical curve. 
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At pH - 3 - 4, the function levels off at a Zwbar value of -2 indicating that two 
protons have been added to the ligand, resulting in a di-protonated ligand at low pH. 
Below pH 7 the predominant species is PCUL while above this pH the predominant 
species is PCULW. The Zwbar rises to a limiting value of 2.5 indicating that LH, 
LH2 and LH3 are the predominant species in solution. 
The three protonation constants determined by EST A optimization of potentiometric 
data for PCUL are pKl = 8.71, pK2 = 7.95 and pK3 = 2.89 as shown in Table 2.9. The 
low pK3 or rather the acidity of the pyridyl nitrogen is due to the electronic repulsion 
effect and base weakening effect of the protonated methylamine group [3]. The 
standard deviations are relatively low and the agreement between the theoretical and 
experimental curves gave confidence to the results. 
Table 2.9: log~ of the H-PCUL system determined at 25°C in 0.15 mol/elm3 (Cl') Na +. std Dev 
denotes standard deviation in log~, RcH is the Hamilton R-factor and Rum H its limit. The general 
fonnula of a complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Ligand pqr log~ stdDev logK nT (np) RcH ~imH 
H-PCUL o 1 1 8.71 0.025 8.71 1 (64) 0.028 0.012 
012 16.66 0.024 7.95 











2.5.3.2 Cu(II)-PCUL complexation 
The complex formation function, ZM-bar is only strictly defined for simple 
mononuclear complex formation [21]. From Figure 2.25 the ZM-bar does not start at 
zero indicating that at the start of the titration complexation is already occurring. 
Therefore, the curves level off at 1, indication that the ML species is formed. In the 
pL range 13-4.5 the curve is horizontal indicating that no further complexation occurs. 
Below pL 4.5, fanning back of the ZM-bar begun indicating the formation of the 
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Figure 2.25: Formation function curve, ZM-bar against pL for the Cu(II)-PCUL at 25°C in 
O.15moVdm3 (Cn Na+. M:L ratio 1:2 is displayed. 
A plot of the deprotonation curve function against pH is given in Figure 2.26. The Q-
bar curve function is 2.3 at the point it is clear that for the Cu(II)-PCUL system, 
complexation occurs at the start of titration, since at pH 2.68 the Q-bar curve function 
is 2.3. At pH 5 the Q-bar curve function intersects the n-bar at 2, indicating that two 
protons are lost upon Cu(II)-PCUL complexation. The predominant species at pH 5 is 
ML reaching 99% formation at pH 3.5-8.5 as shown by Figure 2.27. The 
complexation of Cu(II)-PCUL is complete at pH >5 this is shown by the Q-bar curve 
function running parallel to the n-bar. At pH 9.94 Figure 2.27 shows the formation of 
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Figure 2.26: Deprotonation function curve, Q-bar against pH for the Cu(II)-PCUL at 25°C in 
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Figure 2.27: Species distribution curves ofCu(II)-PCUL as a function of pH. 
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Three protonation constants derived from the experimental data and are quantitatively 
related to the fonnation constants (logPpqr'S) which were used to investigate the 
reproducibility of the experimental data and the reliability of the evaluated Ppqr values. 
The EST A suit of programs yielded the results given in Table 2.10, the standard 
deviation, R-factor and R-lim are relatively high because of small error associated 
with small volume of PCUL used. 
Table 2.10: log~ of the Cu(II)-PCUL system determined at 25°C in 0.15 mol/dm3 (Cn Na+. std 
Dev denotes standard deviation in log~, RrH is the Hamilton R-factor and ~im H its limit. The general 
formula of a complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Metal-ligand complex pqr logJ3wr std Dev nT (np) Rrtl ~tl 
Cu(II)-PCUL 110 15.38 0.14 1 (64) 0.04 0.01 











2.5.3.3 Zn(lJ)-PCUL complexation 
Figure 2.28 shows a plot of ZM-bar as a function of pL for the Zn(II)-PCUL system. 
The Zn(II)-PCUL complexation pattern follows that of Cu(II)-PCUL system. At pL 
8.5, the theoretical and the experimental curves are similar, however, at pL lower than 
8.5 the two curves differ from each other.. Since this occurs at the buffered region 
where no complexation is taking place, it is therefore not of concern. At pL 3.5-9.5 
the ZM-bar curve function is essentially horizontal indicating that Zn(II)-PCUL 
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Figure 2.28: Formation function curve, ZM-bar against pL for Zn(II)-PCUL at 25°C in 
O.15molldrn3 (Cn Na+. M:L ratio 1:2 is displayed. 
The deprotonation function Q-bar is plotted against pH for the Zn(II)-PCUL system in 
Figure 2.29. At pH 3.5 the Q-bar curve function is not zero, indicating that 
complexation of Zn(II) with PCUL occurs at the beginning of the titration. The Q-bar 
curve function rises and intersects the n-bar at 2 indicating that two protons have been 
lost upon Zn(II)-PCUL complexation at pH 5. This indicates that at this pH region 
the predominant species is Ml. The speciation graph in Figure 2.30 shows that at pH 
range 3 to 9, ~99.9% of the ML species is formed in solution. It is important to note 
that at pH 4- ~.5 the theoretical and the experimental curves are similar. At pH 5-8 
the Q-bar curve function run parallel to the n-bar indicating that the complexation of 
Zn(lI) with PCUL is complete. The theoretical and the experimental curves are 
different to one another at pH 5 to 8; however, this is not of concern since it occurs at 
the buffered region where no further complexation occurs. At pH >9, ML(OH) 
species is formed, Figure 2.30 shows that less than 1 % of this species is formed at pH 
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Figure 2.29: Deprotonation function curve, Q-bar against pH for Zn(II)-PCUL at 25°C in 
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Figure 2.30: Species distribution curves ofZn(II)-PCUL as a function of pH. 
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The model presented in Table 2.11 resulted from the analysis of ZM-bar curve 
function using the ESTA suite of programs. Similar to Cu(II)-PCUL system, R-
factor and R-lim are relatively high because of small error associated with small 
volume of PCUL used. 
Table 2.11: log~ of the Zn(II)-PCUL system determined at 25°C in 0.15 moVdm3 (Cn Na+. Std 
Dev denotes standard deviation in logJ3pq.., RcH is the Hamilton R-factor and Rum H its limit. The general 
formula of a complex is MpLqHr denoted by the stoichiometric coefficient pqr. 
Metal-ligand complex pqr log~ stdDev nT (np) Rcn R.im n 
Zn(II)-PCUL 1 1 0 9.411 0.11 1 (58) 0.13 0.017 












The protonation constants of PCUL and the stability constants obtained from 
complexation of PCUL with Cu(II) and Zn(II) are discussed in relation to amine and 
the pyridyl groups. Figure 3.31 shows the structures of PCUL and related ligands to 
pyridine and amine. The proposed coordination structures for the various species 






Figure 2.31: Structures of Bis-(3-aminoethy-2-aminomethylpyridine )-oxahexacyclo dodecane 
(PCUL), 2-(aminomethyl)-pyridine and glycine 
Table 2.12: Comparison of the stepwise protonation constants of PCUL and related ligands with 
pyridine and amine performed in 25°C in O.15mol/dm3 (Cn Na+. 
Species pyN PCUL enLI 555-NL1 
o 1 1 8.66 8.71 9.9 9.57 
012 2.20 7.95 7.1 7.91 











Table 2.12 shows the protonation constants determined by ESTA optimization of 
potentiometric data for pyN, PCUL, en and 555-N. The third equilibrium constant 
obtained for 555-N is higher than that ofPCUL. The reason for this is that PCUL has 
two unsaturated n-donor pyridyl groups whereas 555-N has one pyridyl group and en 
has none. The unsaturated n-donor pyridyl group is a weaker base in aqueous 
solution than the saturated nitrogen found in en and 555-N. However, the second 
protonation constants obtained for PCUL and 555-N are relatively similar differing by 
0.04 log units. This suggests that the secondary nitrogen donor atoms are protonated 
during the first stage of the protonation process in both PCUL and 555-N, while the 
primary nitrogen donors are protonated in the second stage of the protonation process 
in these two chelating agents [21]. The first protonation constant obtained for PCUL 
is less than that obtained for 555-N. The first protonation constant obtained for PCUL 
is determined for the pyridyl group which requires a very acidic solution, while for 
555-N the same protonation constants is obtained for the amine group. 
2.5.4.1 Complexation with Copper(II) 
The Cu(II)- PCUL complexation reaction was evidences by a colour change from blue 
to light blue. The EST A suit of programs gave the following species 1 1 0 and 1 1 -1 
as shown in Table 2.13. 
Table 2.13: Fonnation constants ofcopper(II) with PCUL and ligands related to pyridine and amine 
perfonned in 25°C in O.15mol/dm3 (Cn Na +. 
Species pyN PCUL en21 555-N21 
1 1 0 9.71 15.38 10.5 18.62 
1 1 -1 -0.01 7.60 7.97 
120 16.13 19.7 
Table 2.31 shows the formation constants of the ligands with Cu(II). The structural 
formular of PCUL has two unsaturated nitrogen donor atoms which are Sp2 
hybridized, which lead to greater character in bonding to the metal ion and hence 
more covalent bonding [2]. Also incorporated to the PCUL is the adamentane moiety, 
the rigidity of the adamentane should increase the stability of the metal by forcing the 











PCUL would form far more stable complexes with Cu(II) as compared to 555-N. 
However, Table 3.13 shows that the equilibrium constants obtained for the formation 
ofML and ML(OH) species for 555-N are much higher than the equilibrium constants 





Figure 2.32: Cu(II)-PCUL coordination structures (coordinated water molecules have been 
omitted). 
Figure 2.32 shows the proposed coordination structures which are used as a guideline 
for discussing the species formed in solution. 1 1 0 species seems to be the most 
predominant or most stable species as indicted by the results given in Table 2.13. The 
ML species may be formed by coordination with all four nitrogens of the PCUL 
ligand, resulting in structure 1. Cu(II) may coordinate with nitrogens of the pyridyl 
groups only resulting in structure 2, however this would be a very weak complex as 
the pK3 = 2.99 (Table 2.12), is far less than pKa's of both amine groups. Also, the 4th 
protonation could not be determined potentiometrically because it was beyond our 
electrode working pH range. Structure 3 represent another possible coordination 
pattern, the 1 1 0 species can be formed by coordination with one of the amine groups 
and one pyridyl group. However, this is the same as the coordination pattern of pyN 
system, which gave a low stability constant 10gKllO= 9.71 (Table 2.13) as compared 
to PCUL system where 10gKllO = 15.38, hence differing by 5.67 log units. 
Cu(II) may coordinate with both amine groups and one pyridyl group resulting in 











only three sites. Structure 5 represents a similar coordination pattern to en except that 
its stability would be lower than en because of the lack of a chelate effect. Since the 
formation constants for 1 1 0 complex of Cu(II)-en it is less than that obtained for 
Cu(II)-PCUL complex, structure 5 is unlikely. Therefore we can conclude that 
structure 1 is most likely structure for Cu(II)-PCUL complex. 
1 1 0 species is subsequently converted to 1 1 -1 (PKll-l = 7.60), through axial 
coordination of the water molecules (structure not shown). 
2.5.4.2 Complexation with Zn(U) 
The formation curves for Zn(II)-PCUL system follows the same complexation pattern 
as the Cu(II)- PCUL system. The Zn(II)-PCUL chemical model in Table 2.11 shows 
two complex species which are 1 1 0 and 1 1 -1 with logp's 9.411 and -0.394 
respectively. The Zn(II)-PCUL complexation begins at pH -3.8 as compared to pH 
-2.2 for Cu(II)-PCUL system. This is because the Zn(II) ion has large size as 
compared to Cu(II), Zn(II) does not favour the deprotonation of the amine nitrogen 
[3]. The stability constants obtained for the Zn(II)-PCUL system are lower than those 
obtained for the Cu(II)-PCUL system in accord with the expected Irving Williams 
stability series. Irving Williams showed that for divalent ions of the 1 st transition 
series, the stability always follows the order Mn< Fe< Co< Ni< Cu< Zn after viewing 
all his data. 
2.5.4.3 Conclusion 
The Cu(II)-PCUL complexation reaction was evidenced by a distinct colour changes 
from sky blue to navy blue. The potentiometric data was put on EST A suite of 
programs which gave the equilibrium and! or formation constants. The three 
protonation constants obtained from EST A optimization of potentiometric data for the 
H-PCUL system are pKl= 8.71, pK2= 7.95, and pK3= 2.89 given in Table 2.9. The 
equilibrium constants together with the proposed model for the H-PCUL system were 
acceptable since the equilibrium constants for H-PCUL were similar to the 
equilibrium constants obtained for the H-Glycine and H-pyN systems. The pKl= 8.66 











we only compared the second equilibrium constants, pK2= 2.38 which was assigned 
for the amino group. The ftrst equilibrium constant for H-Glycine is assigned for the 
carboxylic group (C02-) which is not found in PCUL ligand. It is important to 
remember that the glycine system was included in this study to check the reliability of 
the proposed experimental procedure. 
The in vivo competitor, Zn(II) archived lower stability constants for 1 1 0 and 1 1 -1 
species with logWs = 15.38 and 7.60 for 1 1 0 and 1 1 -1 species respectively. Figure 
2.31 shows the possible Cu(II)-PCUL structures of which through Cu(II)-PCUL, 
Cu(II)-en, Cu(II)pyN, and Cu(II)-555N stability constants comparisons in Table 2.13, 
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3. SPECTROSCOPY AND ANCILLARY STUDIES 
While potentiometry gives an accurate measure of the thermodynamic properties of 
the system, it does not provide any information about the structure of the species 
formed. For this reason spectroscopic studies were undertaken. 
3.1 INFRARED SPECTROSCOPY 
3.1.1 Introduction [1]. 
Infrared spectroscopy is certainly one of the most important analytical techniques 
available to today's scientists. One of the grate advantages of infrared spectroscopy is 
that virtually any sample in virtually any state may be studied. Liquids, solutions, 
pastes, powders, films, fibres, gases and surfaces can all be examined with a judicious 
choice of sample techniques. Infrared spectroscopy is a technique based on the 
vibrations of the atoms ofa molecule. An infrared spectrum is commonly obtained by 
passing infrared radiation through a sample and determining what fraction if the 
incident radiation is absorbed at a particular energy. The energy at which any peak: in 
an absorption spectrum appears corresponds to the frequency of a vibration of a part 
of a sample molecule. The visible part of the electromagnetic spectrum is by 
definition, radiation visible to the human eye. IR spectroscopy is included in this 
study to determine the Cu(II)-PCUL complexation sequence. 
3.1.2 Experimental 
5.4x10-6 mol stock solution of PCUL was prepared in 5 cm3 glass vial and 2.48-5 
moles of Cu(II) was then added into the stock PCUL solution, resulting in 1:2 metal to 
ligand molar ratio. IR spectra were recorded at 25°C on a Perkin Elmer Spectra One 
FT-IR spectrometer (Overhead-ATR ZnSe top plate). The pH of the resultant 
solution was adjusted to pH's 2.33, 4.02 and 6.91 using NaOH or HCl. A micro-pH 
2000 meter was used to measure the pH of the solution. Before running IR analysis 
the solutions were frees dried and the KBr discs were prepared by mixing the solid 
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Figure 3.1: Infrared spectrum ofCu(II)-PCUL in KBr disc as a function of pH. 
The infrared (KBr) spectra of Cu(II)-PCUL complex as a function of pH are shown in 
Figure 3.1. It was expected that the complexation would commence at pH 2.33 due to 
the attachment of the pyridyl groups [2]. From potentiometric results, at pH 2.68 the 
Q-bar curve function is 2.3 indicating that two protons are lost upon Cu(II)-PCUL 
complexation, Figure 3.1 confirms that complexation does occur at low pH. At pH 
2.33 two absorption bands 1373 and 1459 cm-1 are observed. The 1373 cm-1 is 
assigned for the pyridium ion and the 1459cm-1 is assigned for pyridine. However as 
the pH of the solid complex is increased these bands disappear. At pH 4.02 the 
absorption bands at 3410 and 3454 cm-1 broaden and the intensity of these bands 
increases with pH. These bands are replaced by one absorption band at 3425 cm-1 at 
pH 6.91 which was assigned to the amine N-H stretching vibration in the PCUL 
ligand. This indicates loss of protons from the amine due to complexation. The 
predominant species at this pH is ML species reaching 99% formation as shown by 
Figure 2.27 from the potentiometric results. 
All complexes exhibit a sharp maximum in the 1590-1600 cm-1 region attributable to 
the coupled stretching modes of the pyridyl C-C and C-N bands which have been 
shown to exhibit small frequency shift and a marked intensity increase on 
coordination of the pyridyl nitrogen atom [3]. At pH 4.02 the absorption band at 1609 











is also coordinated. Steenland et.al, have assigned the 1591cm-1 band to a carbonyl 
group with strong coordination through oxygen [4]. The IR spectrum given in Figure 
3.1 does not show the presence or existence of the 1591 cm-1 band. From this, we can 
therefore conclude that the adamentane oxygen is not involved in coordination. 
3.2 NUCLEAR MAGNETIC RESONANCE 
3.2.1. Introduction 
NMR is an important tool in the investigation of chemical structures and reaction 
mechanisms and has been extended to whole body imaging in medical diagnosis [5]. 
In chemistry the use of this technique was initially restricted to the study of protons, 
but developments in instrumentation and procedures have resulted in the routine study 
of nuclei with spin other than Y2 and with low natural abundances [5]. In this study, 
NMR was used to determine the sequence of protonation in PCUL and also to 
determine the coordination site of Cu(II). 
The average pKa of the protonation site can be estimated from the inflection point in 
a plot of the chemical shift against pH [6]. In both protonation and complexation 
reactions the presence of the proton or metal shifts the NMR signal arising from the 
protons attached to the neighbouring carbons [6]. The resulting signal is influenced 
by the nature of the bonding and the degree of complexation. 
3.2.2 Experimental 
In 5ml glass vials, 0.01358mol/dm3 PCUL stock D20 solution was prepared and the 
I H NMR spectra recorded at 300 MHz. The pH of these solutions was adjusted using 
concentrated NaOD or DCl. Tertiary butyl alcohol was used as an internal standard 
since it is not susceptible to pH changes. A micro-pH 2000 meter was used to 













For copper(II)-PCUL complexation, solutions of 1:2 molar ratio of metal to ligand 
were prepared in D20 and scanned in the pH range 2-11. The chemical shifts (ppm) 
of both protonation and complexation were plotted as a function of pH [5]. 
3.2.3 Results and Discussion 
Figure 3.2 shows a plot of chemical shift as a function of pH where a, b, c, and d refer 
to chemical shift of protons attached to carbons of the pyridyl ring. Figure 3.3 shows 
the similar plots but for (e), (t), and (g) which refer to the chemical shift of the 
protons attached to the carbons next to the amine group . 
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Figure 3.2: Change in proton chemical shift (ppm) for protons as a function of pH for PCUL 
(0.01358 moVdm3). 
From Figure 3.2, a change in chemical shift is seen in the pH range 1.2 - 3.2. 
However as the pH of the solution increases, no dramatic change is seen as the 
chemical shift curves level off. The last protonation constant (PKa) of 2.35 which is 
assigned for nitrogen of the pyridyl group was estimated from the inflection point in 
the chemical shift. This pKa is similar to pK2 = 2.38 of glycine and pK3 = 1.95 of 
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Figure 3.3: Change in proton chemical shift (ppm) for protons as a function of pH for PCUL 
(0.01358 moVdm3). 
87 
Figure 3.3 shows that there is no significant change in the chemical shift of e and g 
but for f proton signal, a dramatic change in chemical shift is observed at pH 7.2-9.2 
region. This is a clear indication that the central amines are undergoing protonation. 
Theoretically, a significant change in chemical shift is observed in protons attached to 
carbons closest to the protonation site and Figure 3.3 confirms this theory. The 
protonation constant, pKa 8.16 assigned for nitrogen of the amine group was 
estimated from the inflection point in the chemical shift and is close to the two pKa' s 



























- .., , 
~ 
, 0 .' • 
0 
, 
: • 61 2 1 - "l , " " • - " ~ . 











Figure 3.4 shows the effect of Cu(II) on the proton spectrum of PCUL. Cu(II) is 
paramagnetic, which can affect both the chemical shift and relaxation time of the 
protons [3]. This manifests itself as broadening and shifting of the NMR signals [3]. 
The broadening effect is usually more apparent unless there is pseudo-contact shifts. 
For non-macrocyclic ligands Cu(II) exchange is normally very rapid, hence only an 
average spectrum will be seen [3]. The spectrum shows that at pH 2.43 complexation 
occurs. The e proton signal remain relatively sharp while a, b, c, d, f, and g proton 
signals broaden with increasing pH and eventually disappear. 
A significant broadening is observed for the f proton signal which disappears first. 
This suggests that complexation begins at the central amine. The fact that the pyridyl 
protons also broaden indicates that this group is also coordinated. The proton signals 
do not broaden at the same rate; this indicates that they are not at the same distance 
from the metal ion. Since this is a dynamic system it is not possible to conclude that 
both central amines are coordinated at the same time. It is possible for copper(II) to 
be rapidly exchanging between the two sites. Figure 3.5 shows a possible 
coordination pattern for the Cu(II)-PCUL complex. 
Figure 3.5: Cu(II)-PCUL coordination pattern. 
The potentiometric results given in pages 77-80 show that the preferred coordination 
structure is structure 1. These findings confirm the NMR results since Figures; 3.2 
and 3.3 indicated that the protons closest to the protonation site will be deprotonated 
first and hence Cu(II) will complex in those sites first (Figure 3.4). Thus Cu(II) 











3.3 UV-VIS Analysis 
3.3.1 Introduction 
The formation of the different complexes can be followed by UV -visible 
spectrophotometry because distinct colour changes occur as a result of the changing 
speciation of the solution with pH [7]. The variety of colours among transition metal 
complexes arise from electronic transitions between energy levels whose spacing 
correspond to the wavelengths available in visible light [7]. These transitions in 
complexes are frequently referred to as d-d transitions because they involve molecular 
orbitals that are mainly metal d in character [7]. The electronic spectra of complexes 
can provide valuable information relating to bonding and structure since spacing 
depends on factors such as geometry of the complex, the nature of the ligand present 
and the oxidation state of the central metal ion [7]. 
UV -visible spectrophotometry can in fact be used as a supplementary technique to 
glass electrode potentiometry for quantitative analysis of equilibrium reactions, 
thereby determining formation constants [8]. This technique can be used 
diagnostically for determination of the number of possible chemical models present in 
solution not available with potentiometry, by carrying out a graphical or computer 
based rank analysis of the wavelength absorbance matrix [7, 9]. However, UV-visible 
spectroscopy does not evaluate stability constants as precisely as potentiometric data. 
This is due to the fact that UV -visible spectra of most complexes contain broad 
overlapping absorption bands and parameter correlation arises [9]. The 
potentiometric data may lead to a more precise analysis of the wrong model, whereas 
spectrophotometric data will indicate the correct model but give a less precise analysis 
of it [9]. Hence it is necessary to combine both spectrophotometric and 
potentiometric data for defining the chemical model and for evaluation of the stability 











3.3.2. Electronic Spectra of Metal Complexes. 
Electronic spectra from transition metal ions and complexes are observed in the 
visible and ultraviolet regions [10]. The spectra arise because electrons may be 
promoted from one energy level to another. The absorption spectra show the 
particular wavelengths of light absorbed, that is the particular amount of energy 
required to promote an electron from one energy level to a higher level, while 
emission spectra show energy emitted when the electron falls back from the excited 
level to a lower level [to]. 
The following selection rules are pertinent to electronic absorption spectroscopy: 
1. Transitions between states of different multiplicity are 
multiplicity forbidden, i.e., electronic transitions in which the 
spin of an electron changes are forbidden [11]. 
2. In a molecule with a centre of symmetry, transitions between 
two gerade (g) or two ungerade (u) states (i.e., g ..... g or u-+ u) 
are Larport forbidden. The allowed transitions are g -+ u and 
u-+g [11]. 
Rule 1 indicates that a d2 configuration in an octahedral field would have three 
transitions that are spin allowed; 
3T 3 19 -f T2g 
3T1g -+ 3A2g 
3T1g -+ 3T1g [7]. 
As a result of rule number 2, d-d transitions in octahedral complexes are Larporte 
forbidden and therefore many complexes will not have intense colours [to]. 
However, there are mechanisms by which selection rules can be relaxed so that 
transitions can occur, even if only at low intensities [11]. Most ions do not have 
perfect symmetry and are distorted so that the centre of symmetry is destroyed, 
resulting in mixing (hybridization) of d and p orbitals [11]. Thus d-d transitions of 











often absorb more strongly than octahedral complexes of the same oxidation states 
[10]. The bands associated with formally spin forbidden transition gain enough 
intensity to be observed because the spin selection rule breaks down somewhat in 
complexes that exhibit spin-orbit coupling. The spin-orbit coupling and Jahn-Teller 
distortions often lead to more complex spectra than predicted with the spin selection 
rule [10]. 
3.3.3. Electronic Spectra of Copper Complexes 
The aqueous chemistry of copper is largely devoted to copper(II) compounds because 
copper(I) compounds are quite unstable in aqueous solution [12]. Cu2+ has an 
incomplete d shell configuration (Ar) cf and its complexes are predominantly 
paramagnetic and highly coloured [12]. The cf electronic configuration is the whole 
equivalent of i configuration [13]. Arising from these configurations is only the one 
Russell-Saunders term or free ion ground state, namely 2D, which has the Eg and T2g 
crystal field components [13]. In essentially an octahedral field the 5 degenerate d-
orbitals are split, due to their spatial arrangement, into 2 higher energy Eg and 3 lower 
energy T2g orbitals or electron wave-functions with energy difference of 10Dq (ligand 
field splitting). For the cf electronic configuration the ground state of the complex is 
given by 2Eg and the excited state, at energy of 10Dq above this, by 2T g, which is the 
inverse of the d1 case. Thus essentially only one absorption band occurs in the visible 
region of copper(II) complexes due to the d-d transition, of which Amax is an indication 
of the ligand field stabilization energy,IODq [13]. 
Furthermore, not only does the nature of the ligand but also the number of ligands in 
the coordination sphere of the metal ion affects the size of 10Dq [11]. For example 
the series of ammine aqua cupric complexes [Cu(H20)6-n (NH3)n]2+, shows absorption 
maxima at 790, 745, 680, 645,590 and 640nm for n= 0 to 5, respectively [11]. Based 
on this trend it was thought that by evaluating Amax of the individual species, this 
would indicate the particular coordination involved [11]. 
The ligand strengths of amines towards copper(II) are in the order NH3> RH2> 
R2NH> R3N [12]. In aqueous solution Cu2+ ion has absorption and magnetic spectra 











of difference in energy between orbitals (lODq) being 12,500cm-l [12]. The ligand 
field strength of water compared to other donors is shown by the order; CI < H20 < 
pyridine < NH3 < 1,2-diaminoethane [14]. The ligands considered are those 
containing donor groups likely to be encountered in biologically-important molecules, 
especially proteins [15]. The donor atoms are: N(amino), N(peptide), N(imidazole), 
O(carboxylate), 0 (peptide), H20 and OH- l [12]. The Amax (vmax) of the d-d band 
(aqueous solution spectra) can be expressed as the sum of individual ligand-field 
contributions from the four donor atoms which, with copper, define the square plane 
[14]. 
Several complexes of copper(II) with polydentate ligands containing nitrogen have 
been studied and the type of complex formed by copper(II) with these ligands depend 
on both the number of the donor atom and the sterlc requirements of the ligand 
molecule [14]. Copper(II) peptide complexes have been studied as models for 
copper(II)-proteins interactions [14]. It was observed that strong copper(II)-
N(peptide) bonds are formed when protons are ionized from peptide nitrogen atoms 
[14]. 
Billo has proposed a method for calculation Amax for a tetragonally distorted Cu(II) 
complex, with axially coordinated water molecules [14]. This is calculated by the 
formula; 
Veale = L Vi 3.2 
Where Vi (xl03cm-l ) is the energy contribution by atom i. From the above equation 
the contributions of each peptide and amino nitro gens to the Veale are: 
V(amino)= (4.53 ± 0.07) xl03 cm-l 
V(peptidegroup) = (4.85 ± 0.04)xl03 cm- l 





A value of3.38xl03 cm-l was reported for oxime nitrogen [Cu(H2dmg) Ch] (H2dmg = 
dimethyloxime, ",max = 770nm) [14]. The effect of the rest of the atoms of the ligand 
molecule is assumed to be either negligible or additive onto the direct effect of the 











Billo's equation can predict Amax of several of these types of complexes with good 
accuracy; however, the equation cannot predict absorption maxima of mixture which 
are likely to be present in solutions containing axially coordinating solvent molecules 
such as water [14]. 
3.3.4. Data Analysis 
A solution of metal ion and ligands will normally contain a number of different 
species at different concentrations [9]. These species will contribute to the absorption 
spectrum and thus the spectrum will be the sum of all the species present [9]. 
Obtaining the spectrum of a single species is rather impossible unless it is the only 
species present. 
The concentration of species in a system may be determined by measurement of the 
absorption of radiation by the species [9]. A relationship relating concentration of the 
absorption is the Beer-Lambert law, which can be expressed in the following formula 
[9]; 
IOglO (1011)= E cb 3.6 
where 10 and 1 are the intensities of incident and transmitted radiation respectively, c 
is the molar concentration of absorbing species, b is the thickness of absorbing layer 
and E is the extinction coefficient [9]. The term log (loll) is called the absorbance and 
is represented by the symbol A, with this law becoming, A = E cb [11]. The Beer-
Lambert Law can be expended to give a linear combination of terms for each 
individual species, for electronic absorption spectra of solution containing more than 
one absorbing species as follows; 
3.7 
where Ell, El and Enl are molar absorptivition coefficients of species 1,2 and n at the 
same wavelength Iv and Cl,C2 and Cn are their respective concentrations [9]. If the path 











solution at wavelength A. and has value of E3 equal zero, then it does not absorb in the 
chosen spectral region and therefore does not influence Aob/ [9]. 
Complexometric solutions may be made up of a number of solutions of different 
metal ligand concentrations and pH [9]. The spectra of the individual species can be 
calculated by solving a set of linear equations (equation 3), if the UV/visible spectra 
of these solutions are obtained at a number of wavelengths [9]. It is advisable to 
adjust the pH of the metal-ligand complex solution by using strong acids and alkalis 
such as HCI and NaOH since they do not absorb appreciably in the spectral region of 
interest [9]. 
Calculation of E can be done using a specially designed computer program that 
requires an input file with all the information relevant to the chemical system being 
studies, which includes amongst other parameters the concentration values of each 
chemical species present in the reaction [9]. These concentration values are 
calculated on the basis of the stability constants determined from potentiometric 
analysis [9]. The values of E are then plotted against wavelength to give a spectrum 
showing the absorption bands of each chemical species [9]. The existence of a smooth 
spectrum is not inherent in the data analysis since the data is analyzed independently 
at each wavelength, so if one is obtained it lend confidence to the proposed 
potentiometric model [9]. A wrong chemical model is indicated by a disjointed 
spectrum, which will be formed when the stability constants and the concentrations 
are incorrect [9]. After having electronic absorption spectral information for each of 
the complex species the nature of the ligand field environment of the central metal ion 












Spectrophotometric titrations were performed for PCUL-Cu(II) complexation. An 
aqueous solution containing 1:2 metal to ligand ratio was prepared and measured over 
the pH range of 2-11. During titration the pH of this solution was adjusted by adding 
small amount of concentrated NaOH or HCI and the solutions were kept at 25°C. The 
titrations were carried out manually allowing for the measurement of absorbance 
versus wavelength measured out after each addition of the titrant. The absorbance 
readings were taken automatically at 2nm interval in the wavelength range of 340-820 
nm Hewlett Packard 8452A Diode Array Spectrophotometer. 
3.3.6 Results and discussion 
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Figure 3.6: Electronic spectra of the Cu(II)-PCUL solution at 1:2 metal to ligand ratio as a 
function of wavelength (nm). 
Figure 3.6 shows the absorption spectra for Cu(II)-PCUL system versus pH which are 
obtained in the pH range 2.03-8.69. The observed broad absorption bands for these 
species are due to the expected 2 A1g 2B1g, 2B2g 2Eg 2B1g, characteristic of d
9 
tetragonally distorted Cu(II) complex [16]. As the pH of the solution is increased, a 
shift in absorbance (Amax) is observed indicating the presence of different Cu(II)-
PCUL species. Figure 3.6 shows that at pH 2.03, an absorption maximum of 645nm 











At pH 2.03 the predominant species is 1 1 0 with logKl 10= 15.38 as given in Table 
2.10. As the pH of the solution is increased a shift in absorbance ("-max) is observed 
indicating an increase in the formation of the 1 1 0 species. This is also seen from 
Figure 2.26 where at pH 3.5 to 8.5 1 1 0 species is dominant. The predominant 
species at pH 2.03 to 8.69 is 1 1 0 species since 1 1 0 species reaches 99 % formation 
at pH > 8.5, thus only 1 % of 1 1 -1 species is formed at this pH therefore we did not 
need to calculate to calculate the absorbance of individual species. 
Table 3.1: Wavelength absorbance maxima (A.nax) corresponding to molar extinction 
coefficient (e) of the ML and ML(OH) species. 
pH Species 8 (dmJI moll cm) Wavelength (nm) 
2.33 1 1 0 36.06 645 
8.69 1 1-1 50.04 630 
From Table 3.1, the molar extinction coefficient (8) and "-max for 1 1 0 and 1 1 -1 
species increase with increasing pH. However, the wavelength decreases with 
increasing pH. Hence the value of 8 increase in the order 1 1 0 < 1 1 -1. 
3.4 THE BLOOD PLASMA MODEL 
In biological systems metal ions play an important role [17]. Metal ions such as 
calcium(II), magnesium(II), iron(II), cobalt(II), copper(II) and zinc(II) are considered 
to be essential for health in human [17]. The greater percentage of metal ions is 
bound to proteins in biological fluids [19]. Only a small fraction of these is bound to 
low-molar-weight (l.m.w) compounds, mainly amino acids [19]. There are also metal 
ions that are considered to be toxic to the human system and they tend to compete 
with the essential metal ions for binding sites on the ligands of blood plasma [20]. 
Such metal ions include; palladium(II), mercury(II) and cadmium(II) [20]. In 
biological fluids, free (hydrated) metal ions exist only at extremely low concentrations 
and these concentrations cannot playa significant role in physiological processes [19]. 
Metals bound to l.m.w. compounds playa major role in many biological and 
physiological processes such as; intestinal absorption, cell absorption and renal 











1. as intermediates when metal ions are inserted into or removed from certain 
metalloenzymes or carrier proteins, 
2. in the transfer of certain metal ions across membranes, 
3. in keeping essential metals in solution and 
4. in altering the potential of certain redox couples. 
Copper is a biologically essential metal ion [15]. In blood plasma, 90% of the copper 
is irreversibly bound to ceruloplasmin, 10% is reversibly bound to serum albumin, 
and a small amount, <1 %, is distributed amongst low molecular weight complexes, 
predominantly [Cu(hisdinate)(cystinate)] [15]. In patients with inflammatory disease, 
elevated plasma copper levels are found and these levels return to normal upon 
remission [21]. While the role of copper is unclear, it is thought that it is the low 
moleculer weight fraction which is responsible for the anti-inflammatory activity, 
possibly by making the copper available to superoxide dismutase [21]. 
It is important to note that the total concentrations of Mn(II), F e(II) , Cu(II), Zn(II) and 
Pb(II) in normal blood plasma are between lxlO-1 and 2xlO-5 mol/dm3 [19]. Hence 
the corresponding minute concentrations of the respective free ions are far below the 
limit of detection by any other analytical technique [19]. However, it is also very 
difficult to obtain information from large chemical systems due to their complexity 
[19]. Therefore it is not presently possible to set up a single simulation of blood 
plasma because of large number of compositions found in the plasma, as the model 
contains all the species present in blood plasma and as a result computer models 
simulating the complex systems have been developed [19, 17]. 
In order to understand the effect of the ligand on the equilibria, formation constants 
for the ligand together with the species determined in vitro are entered in the ECCLES 
(Evaluation of Constituent Concentration in Large Equilibrium Systems) [17]. 
ECCLES solves the relevant mass balance equations and displays the resulting 
species distributions in ordered way to enable changes in concentrations of major 
complexes to be readily monitored [17]. Formation constants of the ligand (drug) and 
the species of interest determined in vitro are incorporated into the database in order 











This database, on inclusion of the ligand concentration, is interrogated by the 
ECCLES computer program to yield results pertaining to the influence of this ligand 
on these equilibria [17]. MIX is one of the major features of ECCLES which 
generates estimate of the equilibrium constants for the many mixed (ternary) 
complexes that might be important in the blood plasma [17]. 
Considering the blood plasma compartments as a closed system, the blood plasma 
mobilizing index (p.m.i) is a convenient measure of the ability of the chelating agent, 
at a given concentration, to mobilize metal-ions from the labile protein-bound fraction 
[19]. 
The design of copper-based anti-arthritic agents is based amongst other properties on 
the ability of the ligand to bind strongly and selectively to the metal ion of choice as 
reflected by the p.m.i [18]. The p.m.i is defined as the ratio of the total concentration 
of low moleculer weight metal complex species in the presence of the drug to that of 
the normal plasma [17]. In addition, the p.m.i is a measure of the ability of the 
administered ligand to move metal ion to the low molecular weight (l.m.w.) fraction 
[17]. It is based on the premise that the free concentration of the metal ion is 
buffered and hence held constant during any reasonable perturbation [17]. The 
calculation of p.m.i takes into account competition between the ligand and all the 
endogenous metal ions and low molecular mass ligands present in blood plasma [17]. 
3.4.1 Simulation Studies 
In order to establish the true selectivity of PCUL for Cu(II) over Zn(II) in vivo, the 
plasma mobilising index (p.m.i) was calculated. The inclusion of Zn(II) is due to its 
high concentrations in blood plasma relative to Cu(II) [20]. A comparison of the 
stability constants alone is not enough to conclude the stability of Cu(II)-PCUL in 
blood plasma because of high concentration of Zn(II) in plasma which may compete 
for the ligand [18]. The total ligand concentration in the calculations was raised over 
the range 10-00 _10-10 mol/elm3• 
The Cu(II)-PCUL p.m.i was calculated by incorporating the formation constants 
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Figure 3.7: Logarithms of Cu(IJ) and Zn(II) plasma mobilizing indices as a function of log[PCUL]. 
The pmi curves for Cu(II) and Zn(II) with PCUL as a function of 10g[PCUL] are 
given in Figure 3.7. The potentiometric studies in Chapter 2 show that PCUL forms 
far more stable complexes with Cu(II) than with Zn(II). However, Figure 3.7 shows 
that PCUL mobilises Zn(II) more than Cu(II) in blood plasma. The reason for this is 
the relatively high affInity of PCUL for Zn(II) than Cu(II). This proves that looking 
at the stability of Cu(II) alone is not sufficient because as in this case Zn(II) being 
present in much higher concentration is able to compete for PCUL [22]. This also 
shows the importance for simulation models and inclusion of other completing metal 
ions in the study [3]. The curves in Figure 3.7 show PCUL mobilizing ability is in the 











3.5 Octanl-I-oll water Partition Coefficient 
3.5.1 Introduction 
Hydrophobicity is often used to describe the free energy changes involved in the 
movement of a drug from the aqueous phase to the lipid bilayer but may also be 
important in the binding of the substrate to the macromolecular active site [23]. 
The most widely used physical property for predicting the biological effects of an 
organic chemical is the partition coefficient (Pow) [24]. Since we intent to determine 
the hydrophobicity of Cu(II)-complex as a drug, Pow is defmed as the ration of the 
equilibrium concentration of a dissolved Cu(II)-complex in a two phase system 
consisting of two largely immiscible solvents, l-octanol and an aqueous phase [25]. 
This can be expressed by the following equation [25]: 
3.9 
Where [CU2 +]org and [CU2 +]aq are the concentrations of Cu(II) in organic phase and 
aqueous phase respectively. 
Speciation changes with pH and the different species have different partition 
coefficients, hence the amount of the Cu(JI) transferred from aqueous solution to 
organic layer changes with pH [6]. In order to enhance the transport of a chelating 
ligand across membrane in vivo, it is useful to enhance the hydrophobicity of the 
chelating agent so as to improve its tissue permeation and therefore minimize loss of 
the complexes formed from the body via renal filtration [16]. In this study, 1- . 
octanollwater partition coefficients were determined in order to predict and provide an 












Traditionally, the experimental method for determining 10gPow is the shake-flask (SF) 
method, which is adapted as the standard OECD (Organisation of Economic Co-
operation and Development) method [25]. The SF method is not suitable for highly 
hydrophobic compounds because of the formation of octanol emulsions in aqueous 
phase [25]. To overcome the formation of emulsions in the aqueous phase which is 
the limiting factor for SF a column generator technique and a slow-stirring (SS) 
methods were developed [25]. Since the SS method requires long equilibration times 
of between 2 and 5 days, SF technique became a method of choice in our study [16]. 
1ml of Cu(II) (0.005 molldm3)-PCUL (0.018 molldm3) solutions were mixed in 4 ml 
pill vials and adjusted to pH's 2, 3,4 and 7 using NaOH. After adjusting pH, 1 mlof 
l-octanollwater was added into each solution. The solutions were then shaken for 7 
minutes and allowed to stand at constant temperature so as to allow the two phases to 
separate. 
3.5.3 Results and Discussion 
Table 3.2: [Cu2+] in l-octanol and Cu(II) in water for the 
determination of logP ow as a function of pH. 
pH [Cu2+] organic [ Cu2+])aqueous 10gPow 
2.33 11.1 130 -1.069 
3.34 7 141 -1.305 
4.02 10.5 119 -1.055 
6.91 6.8 132 -1.288 
Average 10gPow = -1.18 
The results obtained for partition coefficient are given in Table 3.2. From these 
results the average 10gPow for Cu(II)-PCUL complex was calculated in order to 
predict the lipophilicity of this complex. For a drug to be considered lipophilic, the 











10gPow values are negative (-1.069, -1.305, -1.055, -1.288), indicating that Cu(II)-
PCUL complex have some hydrophilic character which is enhanced by the 
adamentane cage moiety. Octan-1-oV water partition coefficient values have been 
reported recently for highly hydrophobic (logP ow > 6) and highly hydrophilic (logP ow 
<-2) substances [24]. 
The potentiometric studies in Chapter 2 show that the predominant species in solution 
is ML at pH range 2.33-7. Therefore we can conclude that at this pH range the ML 
species of Cu(II)-PCUL complex is hydrophilic and this is confirmed by the negative 
average LogP ow (-1.18) of this complex. 
3.5.4 Conclusion 
In this Chapter distinct colour changes from light blue to navy blue were observed for 
all experiments namely; blood plasma, infrared and octan-1-oV water partition 
coefficient. These colour changes were the result of increasing pH upon addition of 
of NaOH and or NaOD. These changes were the indication of Cu(II)-PCUL 
complexation pattern. Figures; 3.2 and 3.3 show that the deprotonation of PCUL 
ligand begun at the amine protons with 10gK's 011 = 8.71 and 7.91, then the pyridyl 
protons with 10gKo12 = 2.89. Figure 3.4 further proved that the Cu(II) coordinate to 
the amine group first with 10gkllO = 15.38. 
The absorption bands of interest were observed from the infrared KBr spectra in 
Figure 3.1. These bands are; 1373 and 1459 cm-1 which are assigned for the pyridium 
ion and pyridine respectively. The N-H bands are seen at 3410 and 3454 cm-1 at pH 
4.02. These bands broaden with increasing pH and are replaced by one absorption 
band at 3425 cm-1 at pH 6.91. At pH 2.33 the pyridium ion and pyridine absorption 
bands showing complexation of Cu(II)-PCUL complexation were observed in Figure 
3.1 with 10gKll0 = 15.38 at pH 2.0 from the potentiometric results. Cu(II)-PCUL 
complexation is also observed from Figure 3.6 at pH 2.02 with maximum absorbance 
of 645nm. It is important to note that at pH> 8.5, 1 1 -1 species formation was only 












PCUL mobilized Zn(II) more than Cu(II) in the blood plasma as shown in Figure 3.7. 
In blood plasma Zn(II) is available in much higher concentration than Cu(II), however 
since PCUL have pyridyl groups it was important to investigate if the pyridyl groups 
and adamentane incorporated in PCUL ligand would enhance the mobilization ability 
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GENERAL DISCUSSION AND CONCLUSION 
It has been shown that copper complexes are able to alleviate the inflammation 
associated with RA [1]. Previous studies with a number of copper(II) chelating agents 
showed a reasonable good competition and selectivity for copper, with enhanced bio-
availability of the metal for alleviation of inflammation associated with rheumatoid 
arthritis (RA) [2]. Research has been carried out in designing copper(lI) chemically 
stable complexes for the use as anti-arthritic agents [1]. 
The research under investigating is aimed at contribute to the development of anti-
arthritic agent. The ligand of interest should be capable of forming neutral species 
under physiological conditions as well as incorporating hydrophobic groups are very 
useful in enhancing exogenous dermal absorption of copper(II) and its subsequent 
endogenous mobilization to facilitates the bio-availability of the metal [2]. 
In our study the solution chemistry of Cu(II) and Zn(II) with PCUL ligand at 25°C in 
0.I5mol/dm3 cr Na+ have been explored by glass electrode potentiometry. The 
potentiometric analysis was carried out in the pH range 2 to 11. Three protonation 
constants have been obtained for PCUL and these constants are similar to those 
obtained at the inflection point of chemical shift against pH graph. However, these 
protonation constants are slightly different from those of the related aminomethyl 
pyridine. 
The potentiometric data analysis gave two possible species; ML and ML(OH). 
Looking at Figure 2.26, from pH 2.00 to 9.50 the predominant species is ML with 
IOg(3110- 15.38. At pH > 9.50 there is the formation of the ML(OH) species through 
the axial coordination of the water molecules with log(311-1 = 7.45. Although the in 
vivo competitor Zn(II) gave lower stability constants than Cu(II) in blood plasma 
model, PCUL mobilized with Zn(II) over Cu(II). Table 3.2 shows that the Cu(II)-
PCUL complex is largely hydrophilic with logPow giving negative values for all the 
pH's studied. This however was expected since adamantane incorporated into PCUL 











The NMR results supported the potentiometric analysis. As the pH was adjusted from 
2.00 to 9.50 the protonation of the amine group was observed. The species 
distribution curve showed that at the acidic region the solution contains mainly ML 
species. IR and NMR studies show that the central amines are coordinated to Cu(II) 
first this indicates that the central amine is closer to the metal ion. The nitrogens of 
the pyridyl group are also coordinated to the metal ion. However since this is a 
dynamic system we cannot conclude that both central amines are coordinated at once. 
UV NIS, IR, and octan-1-oV water partition coefficient experiments were carried out 
until pH 8.69 for UVNIS and pH 6.91 for IR and octan-1-oV water partition 
coefficient. This reason for this is that only 0.21230g of the ligand was available to 
carry out all experiments involved in this study. Before animal experiments may be 
undertaken it will be best to first study UV NIS, IR, and octan-1-oV water partition 
coefficient beyond pH 8.68 and 6.91. The reason for this is to validate the 
complexation pattern observed in potentiometric and NMR analysis. 
This study enlightened some of the problems and challenges associated with the 
development and design of copper-chelating agents for alleviation of inflammation 
associated with rheumatoid arthritis. Until the appropriate Cu(II)-ligand complex is 
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